













This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
 
This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
When referring to this work, full bibliographic details including the author, title, 









Investigating the Role of UBR5, a Ubiquitin-
Protein Ligase of the N-end Rule Pathway, in 








Thesis submitted for the degree of  
Master of Science by Research 
 







a) That the thesis has been composed by me 
b) That the work presented here is my own, except when stated otherwise  
c) That the work has not been submitted for any other degree or professional 
qualification   
 








I would like to thank my supervisors, Dr Mark Ditzel and Prof. Bob Hill, for their 
guidance and valued input during the course of my project. A big thank you to Dr 
David Mellis for all his assistance and advice, technical and otherwise, during this time 
and for always being extremely patient and supportive.  
Thanks to Dr Antonia Sophocleous and Dr You-Ying Chau for their help and valuable 
advice with MSCs work, Helen Caldwell, Elaine Mclay (Histology Research Lab, 
Division of Pathology, University of Edinburgh) and Melanie McMillan (SuRF, Little 
France, Queen’s Medical Research Institute, University of Edinburgh) for histological 
services and members of the MRC IGMM Biological Research Facility for animal 
services.  
Finally, I would like to thank my family and friends. To my Dad, you have been a 
source of encouragement, you always believed in me and helped me to achieve this. 
To my Mum whose constant motivational support and patience for endless phone calls 
has gotten me through my education. To my friends and my brother, you have been 
there with me through a lot of difficult times and supported me always, I know I 





Using a conditional Ubr5 mutant (Ubr5mt) mouse the Ditzel lab identified a novel role 
for the ubiquitin-protein ligase UBR5 in maintaining articular cartilage (AC) 
homeostasis, suppressing osteoarthritis (OA) and controlling heterotopic tendon 
ossification (HO), potentially through influencing the Hedgehog signalling pathway. 
Histological observations revealed aberrant chondrocyte behaviour in both the AC and 
ossifying tendons. Interestingly, application of the Hedgehog pathway inhibitor 
cyclopamine enhanced the Ubr5mt OA and HO phenotypes. Based on these 
observations I hypothesised that UBR5 utilises Hh signalling to control AC and tendon 
homeostasis through influencing AC- or tendon-resident stem/progenitor cell function. 
I planned to address this hypothesis by designing an in vitro cell-based model to 
investigate the chondrogenic potential of UBR5-deficient stem/progenitor cells and by 
investigating the Hh signalling expression pattern in tendons collected from normal 
and Ubr5mt animals. 
To address the molecular and cellular defects on Ubr5mt cells I established an in vitro 
system to culture mesenchymal stem cells (MSCs) and promote their differentiation 
into chondrocytes. First, I optimised the experimental conditions for the extraction and 
culture of bone marrow derived cells from C57BL/6 mice. The identity of the isolated 
cells was confirmed by functional chondrogenesis assays and expression of specific 
MSCs markers. Once I was confident about the isolation and culture techniques I 
aimed to culture cells derived from conditionally Ubr5mt animals. Unfortunately, 
these Cre-recombinase bearing MSCs proved difficult to culture, which severely 
hampered experimentation and made the proposed experimental approach unfeasible.  
To investigate the Hh signalling expression and cellular pattern in tendons affected by 
HO, I compared the presence of various markers in patellar tendons collected from 
normal and Ubr5mt mice. It turned out that the level of IHH and PTCH1, proteins 
involved in Hh signalling pathway, was much higher in the latter.  
Overall, I have identified differential expression of Hedgehog pathway components in 
control and Ubr5mt tendons as well as successfully isolated and cultured MSC. These 
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findings and achievement have contributed to a manuscript and will form the basis of 





Skeletal tissue disorders, degeneration and injuries are frequent and pose a serious 
health problem. They are also one of the most common causes of pain and disability 
in middle-aged and older people. Our knowledge about the way how these diseases 
start and what causes them is still limited, which is one of the reasons why I have not 
developed a successful prevention and therapy yet. In my project I focused on two 
types of skeletal tissues, articular cartilage (AC) and tendon. 
AC is a highly specialised tissue, composed of various proteins, water and cells called 
chondrocytes which covers the end of the bones that form a joint. Healthy cartilage 
has a smooth, lubricated surface which minimises pressure and allows bones to slide 
over with very little friction. AC has a poor blood supply and therefore its ability to 
repair itself is limited. Thus, injuries can lead to severe diseases such as osteoarthritis 
(OA). Osteoarthritis is a degenerative joint condition in which articular cartilage 
becomes rough, brittle and eroded which results in the gradual loss of its cushion-like 
surface and eventually in bone exposure. The main symptoms are joint stiffness, 
decreased range of motion and pain.  
A tendon is a type of fibrous tissue and, similarly to AC, it is composed of protein, 
water and cells, here called tenocytes. Its main function is to connect muscles to bones 
and to help control any type of movement e.g. walking, grasping, jumping. As it plays 
such an important role in body movement, any disorder has a high impact on the 
comfort of people’s lives. Because of a limited blood supply, the healing of tendon 
injuries is complicated, long and almost never fully successful. In addition to tendon 
rupture, it may also lose its flexibility, e.g. as a result of disease called heterotopic 
ossification (HO). HO is a disorder in which bone forms in places where it should not 
like in tendon or muscle. This may occur when they do not heal properly, but it can 
also be an effect of a genetic disorder. 
Our lab (Ditzel team) has found that a certain protein called UBR5 plays a key role in 
controlling OA development and HO of Achilles tendon. At the same time, it 
influences the activity of proteins regulating skeletal tissue development. The proteins 
belong to a group of molecules passing a signal to one another and is called the 
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Hedgehog signalling pathway. I also observed unusual behaviour of chondrocytes in 
AC affected by OA and tenocytes in tendons with HO. Based on these observations, I 
proposed that UBR5 plays a role in maintaining healthy AC and tendons by 
influencing the activity of proteins in the hedgehog signalling pathway. I planned to 
verify this possibility by comparing the presence of various Hedgehog signalling 
pathway proteins in patellar and Achilles tendons collected from mice with UBR5 and 
without UBR5 protein (mutant animal). It turned out that the level of molecules 
involved in the signalling pathway was much higher in mutant animals than in normal, 
wild type mice.  
Further, I decided to examine behaviour of stem cells in which I block the production 
of UBR5. First, I established a model, based outside the living organism, to culture 
stem cells and change them into chondrocytes using wild type mice (no UBR5 
mutation). The next step of my project was to culture cells derived from mutant 
animals lacking UBR5 protein. Unfortunately, the mutant stem cells were more 
difficult to culture than expected and this model did not work.  
Overall, I have identified difference in the expression of Hedgehog pathway molecules 
in control and UBR5 mutant tendons as well as successfully isolated and cultured bone 
marrow-derived mesenchymal stem cells. 
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1.1. The Hedgehog signalling pathway 
 The Hh gene family 
The Hedgehog (Hh) signalling pathway is one of the most important signal 
transduction pathways taking part in the development of animals from invertebrates to 
vertebrates. It is involved in cell differentiation and proliferation, stem cell 
maintenance and tissue polarity.  
The Hh gene was initially identified by genetic screens in Drosophila melanogaster 
over three decades ago. The name came from the cuticle of hh mutant Drosophila 
embryos which, because of the hair-like spikes, resembles hedgehog spines (1). 
Drosophila has just one hh gene (2), while mammals possess three: Sonic hedgehog 
(Shh), Indian hedgehog (Ihh) and Desert hedgehog (Dhh) (3) The first two are more 
closely related to each other than to the Dhh, which is closest to the one found in 
Drosophila (3). All three Hh members take part in mouse embryogenesis acting as 
morphogens (4). Studies using genetic knockout murine models highlighted the unique 
and fundamental roles of each homologue during the development process and in the 
adult organism. Their roles will be described in section 1.2. 
 The canonical Hh signalling pathway 
There is a lot known about the molecular pathway via which Hh ligands act in both 
Drosophila and mammals, and despite the fact that many similarities exist, the 
mechanisms between these two groups are not conserved.  
Hh signalling transduction pathway is unusual because of its induction by inactivation 
of the receptor. In the first step of signal transduction Hh ligand binds to the 12-
transmembrane receptor Patched (PTCH) (5, 6). This represses the inhibitory effect of 
PTCH on the G-protein-coupled transmembrane receptor (GPCR), Smoothened 
(SMO) enabling downstream signal transduction (7). In mammals, there are two 
homologues of the Ptch gene, Ptch1 and Ptch2 instead of one as in Drosophila. These 
two genes seem to play distinct roles in embryogenesis which is demonstrated by 
unique expression patterns and different phenotypes observed in their genetic 
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knockout mouse models. Ptch1-deficient mice do not survive past midgestation due to 
severe defects in the hindbrain and neural tube (8), whereas Ptch2 null animals are 
viable, fertile and display generally a normal phenotype except for developing skin 
lesions (9). Both homologues are known to bind to SMO (10), however, further studies 
showed that PTCH2 has different functional roles in comparison to PTCH1 (11). SMO 
activation is triggered by phosphorylation of its C-terminal cytoplasmic tail (12). 
Molecules playing role in the hyperphosphorylation include Protein Kinase A (PKA), 
casein kinase I (CKI) and G-protein-coupled receptor kinases (GRKs). While SMO is 
generally conserved among vertebras and Drosophila, the site phosphorylated by PKA 
in a fruit fly is not present in mammalian protein, Instead, GRK2 is the kinase 
responsible for the phosphorylation of SMO (13). Phosphorylation of C-terminal tail 
by these kinases leads to a conformational change in the protein structure, results in 
the releasing of the auto-inhibitory effect and promotes the translocation to the surface 
of the cell (12, 14). Activation of SMO causes the upregulation of Hh target genes, a 
process mediated in Drosophila by cubitus interruptus (Ci). The lack of Hh ligand leads 
to proteolytic cleavage of Ci (15). This shortened protein travels to the nucleus and 
acts as a transcriptional repressor (16). However, when the Hh ligand is present, the 
full length Ci stays intact, thus it keeps its ability to activate Hh-signalling target genes 
(17).  
In vertebrates, the transcription factor role of Ci has been divided between three GLI 
(Glioma associated oncogene) proteins: GLI1, GLI2 and GLI3 (18). They act as the 
effectors of the Hh pathway and are differentially controlled by SHH signalling. GLI2 
and GLI3 have both activator and repressor domains, however their final function is 
regulated by proteolytic cleavage, similarly to Ci (19-21). Some studies show that 
these proteins have separate predominant functions, GLI2 plays mainly an activator 
role, whereas GLI3, a repressive role. The third homologue, GLI1 does not have the 
same active protein domains as GLI2 and GLI3, thus it acts only as an activator (20, 
22). Unlike the other two GLI family members, GLI1 is controlled by sequestration, 
not proteolytic cleavage; without Hh ligand this transcription factor is bound and 
thereby, kept in the cytoplasm by protein called Suppressor of fused (SUFU), which 
prevents it from entering the nucleus (23-25). In the presence of Hh ligand, protein 
complex dissociates and GLI1 enters the nucleus, activating signal transduction. 
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Figure 1.1. Schematic representation of canonical Hedgehog signalling pathway 
(A) In the absence of Hh ligand, the signalling pathway is not active. The twelve 
transmembrane protein receptor Patched (PTCH) inhibits the activity of Smoothened 
(SMO), a seven transmembrane protein. GLI, a Hh signalling effector, is stopped from 
entering the nucleus by binding with a cytoplasmic protein called Suppressor of fused 
(SUFU). Consequently, Hh target gene expression is repressed. (B) The pathway is 
activated through binding of one of the Hh ligands, SHH, DSS or IHH (all represented 
as Hh on the figure), to PTCH. It results in repression of SMO inhibition, which 
activates a cascade that leads to the translocation of the SMO to the cell surface and 
allows an active form of GLI to enter the nucleus. GLI, as a transcription factor, 
activates Hh target gene expression.  
B. With Hh ligand 
A. No Hh ligand 
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 The non-canonical Hh signalling pathway 
For many years, the canonical Hh signalling pathway has been in the centre of 
researchers’ attention, however the non-canonical Hh signalling is now gaining more 
and more interest. There are three main types of non-canonical Hh signalling pathway 
described: a) the first one involves Hh pathway components, but GLI proteins do not 
regulate the transcription; 2) the second one is based on the direct interaction of Hh 
family members with other signalling pathways and 3) the third one involves the 
atypical interaction of Hh pathway members with each other (26). A confirmation for 
the first non-canonical route comes from the studies on cell motility. SHH treatment 
of mouse fibroblast cells induced microtubule reorganization after 10 min, whereas the 
expression of GLI transcription factors has not been detected until 6h after treatment 
(27). The second type of non-canonical signalling is supported by research showing a 
direct interaction between PTCH and Cyclin B1, a component involved in the initiation 
of mitosis during the cell cycle. Moreover, the addition of the SHH, the PTCH ligand, 
disrupts the interaction (28). Finally, the last-mentioned type of non-canonical route 
involves the main components of the canonical Hh signalling pathway, however, its 
members are involved in a different manner than in the canonical route. The studies 
suggesting that SHH control the neural cells migration in a SMO-independent way, 
provide an evidence for the third type of non-canonical signalling pathway (29-31). 
One possible function of the non-canonical Hh signalling pathway is that it could 
“cooperate” with the canonical pathway, decreasing the chances for the disruption 
when canonical signalling is aberrant (26), though further studies are needed to fully 
explain the role of this alternative pathway.   
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1.2. The roles of HH signalling pathway in embryonic 
development and adulthood 
 The roles of HH as a morphogen 
Hh proteins play a fundamental role in embryogenesis by controlling growth, fate and 
survival of cells. They are capable of triggering the formation of tissue or organs by 
providing the information about cell positioning. In Drosophila, hh functions as a 
segment polarity gene and hh family members are responsible for the proper formation 
of each segment, together coordinating the normal development of the embryo (1, 32). 
In mice, have been revealed pivotal and unique roles for each Hh homologue in 
embryonic development 
It is hard to imagine how a limited number of ligands in Hh signalling pathway can 
play a crucial role in coordinating such a wide range of intricate processes during 
embryogenesis. However, performing these diverse functions is possible thanks to the 
fact that Hh ligands are morphogens, molecules which act on cells at a distance from 
the source and trigger specific cellular activity in a concentration dependent manner. 
For instance, in Drosophila wing disc, the number of target genes is expressed in a 
response to different level of Hh signal (32). Similarly, in vertebrate neural tube 
different concentrations of SHH protein induce different profiles of transcription factor 
expression (33). 
1.2.1.1. The roles of SHH in embryonic development 
Shh is the most broadly expressed Hh member during embryogenesis and is found in 
three important signalling centres such as the floor plate, the notochord and the limb 
bud (34). Mice lacking Shh exhibited a range of serious defects which spread beyond 
the normal region of Shh transcription, underlining the function of SHH as a long-
range morphogen.  
Shh plays a fundamental role in the formation of some of the internal organs such as 
the lungs and gut (35). It has also been shown to regulate the growth and 
morphogenesis of the teeth (36). Shh also plays a role in skin development (4, 37). 
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As mentioned above, Shh expression is also pivotal for correct development of the 
embryonic limb by contributing to the formation of the normal complement of digits 
(38) and by inducing early cartilaginous differentiation of mesenchymal cells (39). 
Moreover, deletion of Shh leads to, inter alia, severe distal limb malformation and lack 
of vertebrae and ribs (35, 40). 
1.2.1.2. The roles of IHH in embryonic development 
The most examined function for IHH during mammalian embryogenesis is its role in 
formation of the skeleton but since this project was focused on skeletal tissue 
homeostasis, the role of this Hh homologue in the developing bone will be discussed 
in separate section. IHH is also involved in the formation of a number of other tissues 
and organs. It is expressed in primitive endoderm (41), embryonic gut (4, 42) and pre-
hypertrophic chondrocytes in the growth plates and articular cartilage of bones (43-
45). Around half of Ihh null embryos do not survive early embryogenesis because of 
incomplete development of yolk-sac vascular network. Embryos, which survive show 
cortical bone deformation as well as abnormal development of chondrocytes in the 
long bones (44, 46, 47). Homozygous mutations of IHH in humans leads to 
acrocapitofemoral dysplasia, an inborn condition characterised by short stature, short 
limbs and by cone-shaped epiphyses (48). 
1.2.1.3. The roles of DHH in embryonic development 
The least widely understood Hh homologue is Dhh. Although the range of functions 
presented by this protein is more limited compared to other Hh family members, some 
of them are important for normal embryonic development. Dhh is expressed in gonads 
(Sertoli cells of the testis and granulosa cells of ovaries) and their precursors and is 
essential for the formation of peripheral nerves sheath (4, 49). Due to its limited tissue 
expression, Dhh null mice do not present any striking phenotype and are viable, though 
males are infertile due to the lack of mature sperm (49).  
Bitgood and McMahon (1995) also reported that Dhh is expressed in endothelial cells 
of the major blood vessels and in the atrioventricular valve of the heart, which may 
suggest that DHH takes part in the development of the vascular system.  
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 The roles of HH in postnatal development and adulthood 
Besides the well-known roles for HH signalling pathway in embryonic development, 
important functions for its members have also been discovered in postnatal 
development. Shh is expressed by Purkinje neurons which reside in the cerebellum and 
its expression correlates temporally and spatially with the formation of fissures 
demostrating a potential role for SHH in the foliation of the cerebellum by influencing 
the proliferation of granule progenitor cells (GPCs) (50). In vitro studies confirmed 
that SHH has the ability to induce and control proliferation of GPCs in culture (51-54) 
and that normal levels of Shh were pivotal for correct cerebellum foliation (55). These 
studies show the important role of SHH in postnatal development of the brain.  
A number of studies pointed out the role of Hh members in the adult organisms.   For 
example, ventral forebrain neurons express Shh which is required for controling the 
production of some neuronal subtypes in the olfactory bulb (56). Of interest, the 
mature neurons are the source of Shh, which confirms that this protein can direct 
specification of neuronal subtypes both in the adult and in the embryo. Ihh is expressed 
also by mature colonic epithelial cells and it regulates the differentiation of enterocytes 
(57), which highlights an important role of this factor in the adult gut. 
Stem cell populations found in postnatal tissues are also dependent on Hh.  For 
example, SHH plays a crucial role in the proliferation of the neural stem cells located 
in the hippocampus and subventricular zone, with a significant reduction observed in 
the absence of this protein (58, 59). Similarly, IHH is necessary for the proliferation 
of intestinal stem cells (60), This process is pivotal for the continuous gut lining 
replacement and lack of Ihh expression in the villus results in early postnatal death 
(61). All the data described above confirm the crucial role of the Hh signalling pathway 
in adult tissue homeostasis and postnatal development.   
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1.3. Skeletal development in the limb 
As already mentioned, the Hh signalling pathway plays an essential role in the 
development of whole limb, however as the topic of this research is related to 
homeostasis of the skeletal tissues, I will focus here mainly on the development of 
cartilage, bone and tendons.  
There are three cell lineages that are responsible for the development of the skeleton: 
the somites which produces the axial (head and torso) skeleton, the cranial neural crest 
which makes the craniofacial bones and the lateral plate mesoderm giving rise to the 
skeleton of the limbs (62). Proliferating mesenchymal cells from the somatic layer of 
the lateral plate mesoderm accumulate under epidermal tissue to start the creation of 
the limb bud (62). These cells secrete fibroblast growth factor 10 (Fgf10) which, starts 
the signalling cascade needed for limb development.  
There are two known ways by which bone is formed: by 1) endochondral ossification 
(EO) or 2) intramembraneous ossification. Most of the skeletal elements (also long 
limb bones) is formed through the first way. The EO process includes formation of a 
cartilaginous intermediate, which later transforms into bone (63). In mouse 
development, these cartilaginous intermediates form from clusters of mesenchymal 
cells which produce an extracellular matrix (ECM) and consist of type I collagen. This 
creates a template for further skeleton development. Later, these cells differentiate into 
chondroblasts which secrete aggrecan and type II collagen. They become trapped in 
the ECM they secrete and are labelled as chondrocytes. 
Cells in the neighbourhood of the condensations maintain the expression of type I 
collagen and form the perichondrium, which is a structure providing support for 
developing bone and function as the precursor to the cortical bone (64). Later, 
chondrocytes proliferation at the core of the cartilage condensations stops and they 
start differencing into hypertrophic chondrocytes producing type X collagen (65, 66). 
Ihh is expressed by pre-hypertrophic and early hypertrophic chondrocytes (4, 43, 67). 
The secretion of type X collagen leads to the mineralization of the ECM surrounding 
hypertrophic chondrocytes, which is followed by vascular invasion (63). Apoptosis of 
hypertrophic chondrocytes along with invasion of osteoblasts enables the formation of 
true bone. This region acts as a precursor for the trabecular bone which forms fully 
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later during skeletogenesis. The ossification gradually moves to the ends of the long 
bones, named epiphyses, which culminates in the creation of secondary ossification 
centres. Chondrocytes can be found in two locations of the epiphyses; in the articular 
cartilage (AC) and in the growth plate (GP), where they later direct the generation of 
the secondary and primary ossification centres, respectively (68). Chondrocytes in the 
growth plates form columns in which they proliferate, differentiate and eventually, die 
via programmed death (apoptosis). These cellular mechanisms are responsible for 
longitudinal bone growth, orchestrated by the growth plate (69), whereas the same 
process within the articular cartilage leads to the growth of the epiphysis (68). The 
cartilage located in the growth plate is finally replaced by bone.  
 The role of IHH in the developing limb  
IHH plays a pivotal role in skeleton formation and stays active for the majority of 
embryonic and postnatal limb development. As already mentioned in section 1.2.2, 
around 50% of Ihh-deficient mice die during early embryogenesis because of the poor 
development of the extraembryonic vasculature, whereas the majority of the surviving 
embryos display a plethora of severe skeletal defects with some of them dying at birth 
(44). Ihh is expressed in pre-hypertrophic and early hypertrophic chondrocytes and the 
main roles of the protein at this location is the regulation of chondrocyte proliferation 
(Figure 1.2 A), the control of osteoblast development and maturation in the bone collar 
(Figure 1.2 B) and the inhibition of chondrocyte hypertrophic differentiation (Figure 
1.2 C) (44, 70-73). The effect of IHH on chondrocyte hypertrophic differentiation is 
dependent on parathyroid related peptide (PTHrP) expression  (4, 43, 44) (Figure 1.2 
C). Cells at the perichondrium and early proliferating chondrocytes express PTHrP, 
which acts on proliferating and pre-hypertrophic chondrocytes in the growth plate, 
leading to the delay in hypertrophic differentiation of these cells (43, 74) (Figure 1.2 
D). Therefore, PTHrP regulates the number of cells expressing Ihh, and thereby its 
own expression, eventually decreasing the rate of chondrocyte differentiation. This 
negative feedback loop gradually terminates by the constant elongating of the 
chondrocyte columns, which leads to separation of the source of IHH from the 
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GLI2 and GLI3 are fundamental effectors of IHH signalling. Gli2 mutant mice exhibit 
significantly longer cartilaginous growth plates, higher numbers of chondrocytes and 
slower bone formation (76), consistent with GLI2 role as a positive regulator of Hh 
signalling pathway. In contrast, the loss of Gli3 can rescue (to some extent) the 
proliferation and the maturation defects reported for Ihh null embryos (77, 78). 
Figure 1.2. Model of the IHH-PTHrP negative feedback loop in chondrocyte 
differentiation. 
This figure presents the epiphysis of a developing long bone. Chondrocytes proliferate 
and then differentiate along the longitudinal axis of the bone. Ihh is expressed by 
prehypertrophic and early hypertrophic chondrocytes where it induces chondrocyte 
proliferation (A), controls the conversion of perichondrial cells into osteoblast (B) and 
stimulates the chondrocyte production of PTHrP at the ends of the long bones (C). 
PTHrP acts on chondrocytes to maintain their proliferation, consequently inhibiting 
Ihh production (D). When the cells expressing PTHrP are sufficiently distant, IHH 
production increases once again. Ihh expression shown in green. PTHrP expression 














However, some of the Ihh deficient phenotype aspects are not saved by Gli3 loss, such 
as the incorrect osteoblast differentiation and vascularization of cartilage (77), which 
suggests that some other activators must function downstream of Ihh to regulate 
normal bone development. The connection between IHH, PTHrP and GLI3 in the 
developing bone is complicated. As already described, PTHrP and IHH role in a 
negative feedback loop is to regulate chondrocyte differentiation. GLI3 has been 
reported to function as a repressor of PTHrP in distal chondrocytes, whereas IHH acts 
as an inhibitor to the repressor function of GLI3, thus enabling distal PTHrP expression 
(78, 79). However, PTHrP can also act as a positive regulator of GLI3 formation 
through a protein kinase A (PKA) dependent pathway (79). Taken altogether, these 
data emphasise how PTHrP regulate chondrocyte differentiation in growth plate via 
Hh dependent and independent processes.  
There is no clear answer yet if IHH acts directly on the cells which produce PTHrP, 
taking into consideration that these two types of cell are located far apart from each 
other in the limb and PTCH, which is the receptor for Hh, is most highly expressed in 
perichondrial cells close to where IHH is synthesised (43). However, there is evidence 
suggesting that IHH directly regulates PTHrP expression. Immunohistochemistry 
(IHC) data showed that IHH can move long distances in the cartilage (80). 
Additionally, it has been discovered that some of the distally located chondrocytes 
expressing PTHrP, express PTCH (81). Finally, the loss of SMO in chondrocytes 
turned out to disturb PTHrP expression (82). Together, these data show that IHH may 
induce PTHrP expression directly. However, it does not exclude the option that there 
is a secondary molecule, which is upregulated as a result of Hh pathway stimulation 
to trigger PTHrP expression.  
PTHrP deficient embryos exhibit a less severe phenotype, compared to Ihh deficient 
embryos, which suggests that IHH has effects independent of PTHrP (44, 83, 84). 
Consequently, Ihh deficient embryos in which PTHrP receptor is constantly active 
only partially rescue their phenotype (85). Embryos, which express constantly active 
PTHrP receptor controlled by the collagen II promoter, were found to have shortened 
limbs along with lower levels of chondrocyte proliferation in long bones, underlining 
a role of IHH as a regulator of proliferation and hypertrophic differentiation of 
chondrocytes. These results are confirmed by other genetic studies demonstrating that 
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overexpression of Ihh or constant activation of SMO in cartilage leads to increased 
chondrocyte proliferation with no associated changes in differentiation (71). 
Altogether these studies show that IHH plays a crucial role in proliferation of 
chondrocytes, and that, similar to SHH, it functions as a mitogen throughout limb 
development. What is interesting, Ihh can also control the differentiation of 
chondrocytes independently of PTHrP control (73). Kobayashi et al. (73) showed that 
mosaic ablation of PTHrP receptor in growth plate leads to upregulation of IHH, 
ending up in highly stimulated periarticular chondrocyte differentiation and 
lengthening of chondrocytes columns. Together, these results indicate that IHH may 
act independently of PTHrP to control proliferation and differentiation of 
chondrocytes in the developing bone.  
Besides its role in regulating chondrocyte proliferation and hypertrophy, IHH controls 
osteoblast differentiation. Ihh deficient mice do not express Runx2, a factor needed for 
osteoblast differentiation (86). Consequently, skeletal elements which develop via 
endochondral ossification do not ossify (44). IHH was also demonstrated to take part 
in osteoblast proliferation in postnatal bone development (87).    
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1.4. UBR box N-Recognin 5 (UBR5) as Hh regulator 
 Hyd, a regulator of hh gene expression in Drosophila 
Drosophila Hyperplastic Discs (Hyd) belongs to E3 ubiquitin ligase family and it is 
involved in the coordination of Hedgehog signalling pathway through regulation of 
Hh ligand expression. The protein name came from its initial identification as an 
element taking part in the regulation of cell proliferation in Drosophila (88). 
Homozygous hyd mutants are embryonic lethal, whereas temperature-sensitive 
mutants exhibit overgrowth of the wing and imaginal discs, but keep the capability to 
differentiate which suggests that this protein plays a role in regulation of cell 
proliferation in these discs (88).  
Further studies with conditional hyd knockout in the developing eye imaginal discs 
showed its interaction with morphogens. This research revealed that without the 
expression of hyd, the cells in the eye discs overexpress two morphogens: hh and 
decapentaplegic, the Drosophila orthologue of the vertebrate BMP gene family. It 
leads to early differentiation of photoreceptor and excessive growth of the eye tissue 
(89). Together, these studies suggest that Hyd can act as a negative regulator of dpp 
and hh expression, providing an evidence that it influences the Hh signalling pathway 
in Drosophila.  
1.4.1.1. UBR5 and ubiquitin 
UBR5, a mammalian homologue of Hyd, is a highly conserved 309kDa protein 
containing at least five protein-protein interaction sites including a UBA (ubiquitin-
associated) domain, an RLD (RCC1-like) domain, a UBR (UBR box N-recognin) 
domain, a PABC (poly(A)-binding protein C-terminal) domain and a HECT 
(homologous to E6-AP C-terminus) domain (Figure 1.3). 
Thanks to the last domain (HECT) this protein is classified as a E3 ubiquitin ligase 
(90). The relation between UBR5 and ubiquitin goes even further due to the presence 
of UBA domain. The name of the protein comes from the UBR domain, which also 
identifies it as one of the seven human proteins that functions in the N-end rule 
pathway of protein ubiquitylation and degradation (91). In this pathway the proteins 
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having destabilizing N-terminal amino acids are labelled with ubiquitin by E3 ligase, 










 The role of UBR5 in Drosophila and mammals 
One of the numerous cellular processes in which UBR5 is involved, is DNA damage 
response and the evidence for that came from multiple studies. In one example it was 
showed that UBR5 takes part in the regulation of chromatin ubiquitination (93). 
According to the results of this research, the absence of UBR5 and TRIP12 (also E3 
ubiquitin ligase) led to the accumulation of enzymes involved in the DNA damage 
ubiquitination pathway like RNF186 or BRCA1. This study shows a role for UBR5 in 
the regulation of histone ubiquitination in the presence of DNA damage (93).  
A number of studies suggest that UBR5 is also a regulator of the cell cycle. For 
instance, it can bind to CHK2, a kinase, which is involved in the process of 
phosphorylation of various substrates during the cell cycle, resulting in mitotic arrest 
(94). The absence of UBR5 impaired the activity of CHK2 which resulted in an 
inability to react to DNA damage.  
The studies described above, present a clear connection between UBR5, cell cycle and 
DNA damage, which easily explains its role in tumourgenesis. Evidences from 
Drosophila suggest that Hyd function as a tumour suppressor with its loss causing 
1 2792 
UBA RLD UBR PABC HECT 
(180-212) (320-774) (180-212) (2371-2448) (2455-2792) 
Figure 1.3. The UBR5 protein domains.  
UBR5 contains 5 conserved domains identified through sequence analysis. The 
catalytic HECT (Homologous to the E6AP Carboxyl Terminus) domain at the C-
terminus classifies the protein as a E3 ligase; its name come from the presence of 
another domain, UBR. UBA (Ubiquitin-Associated) domain is known to bind 
ubiquitin, PABC (Poly (A)-Binding C-terminal) domain is capable of binding proteins 




hyperplasia during embryogenesis (89). UBR5 is also essential for a proper RNF168-
dependent reaction to DNA damage (93) and its loss has been reported in multiple 
types of human cancer (95, 96), which only confirms a tumour suppressor hypothesis. 
Another UBR5 role reported by number of studies is regulation of transcription and 
translation. In accordance with its role as a transcriptional regulator, EDD, human 
UBR5 orthologue, has been localized in the nucleus (97). As already mentioned, one 
of the protein domains found in UBR5 is RLD (RCC1-like domain). Its three-
dimensional structure resembles the propeller blade structures found in Regulator of 
Chromosome Condensation 1 (RCC1) protein. RCC1 is known to take part in various 
nuclear cellular processes like processing and transport of pre-messenger mRNA (98) 
or chromosome condensation (99). The presence of RLD in UBR5 structure implies 
that this protein could be involved in the process of transcriptional regulation. Thanks 
to the possession of a C-terminal PABC domain, UBR5 can be linked to the translation 
process. The same domain was also found in a poly-A binding protein (PABP), which 
takes part in ribosome recruitment during protein translation (100). UBR5 can 
influence the activity of PABP by controlling the stability of PABP-interacting protein 
2 (Paip2) (101), which, in turn, regulates PABP activity.  
It has also been demonstrated that UBR5 plays a role in the miRNA-mediated gene 
silencing, as UBR5-deficient embryonic stem cells displayed a defective function of 
miRNA pathway in addition to growth defects (102). Altogether, these studies 
underline the role of UBR5 in the post-transcriptional regulation of ligand production. 
UBR5 also plays a crucial role in embryonic development as demonstrated by the 
embryonic lethality of homozygous UBR5-deficient mice (103). A number of studies 
suggest that UBR5 is pivotal for the process of yolk sac vascularisation, therefore its 
absence leads to early embryonic death (103, 104).   
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1.5. Skeletal tissues of interest 
 Articular cartilage and osteoarthritis  
  Articular cartilage (AC) is a highly specialised tissue, composed of collagens, 
proteoglycans, other proteins, chondrocytes and water that covers the articulating ends 
of bones (105). The lack of vascularization makes self-healing process almost 
impossible explaining why most cartilage abnormalities and damage lead to severe 
musculoskeletal diseases such as osteoarthritis (OA) (106). Adult articular cartilage 
has a zonal architecture (Figure 1.4) with different layers characterised by variations 
in chondrocytes types. Cells with functional and phenotypic properties similar to 
mesenchymal stem cell, have been found in the superficial layer of mature AC and are 










Figure 1.4 Structure of mature articular cartilage.  
AC can be divided into several different zones: superficial (stem/progenitor cells), 
middle (proliferating and pre-hypertrophic chondrocytes), deep (hypertrophic 
chondrocytes) and calcified with a tidemark between the first three layers and the 
calcified zone. Every zone is characterised by different type of chondrocytes as well 
the expression of different molecules. 
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Osteoarthritis is one of the most frequent causes of chronic pain and disability among 
middle-aged and older people. It is characterised by gradual loss of AC, subchondral 
bone sclerosis and osteophyte formation (108). Biochemical stress causes the 
pathological changes in chondrocytes which disturbs the cartilage homeostasis (109).  
Some of the studies show that some OA pathologies result from a recapitulation of 
processes present during skeletal development. Hh signalling regulates chondrocyte 
growth/differentiation during embryonic development and after birth (110). It has been 
discovered that Hh signalling is activated in OA and its higher level leads to more 
severe osteoarthritic phenotype. In turn, Hh blockade reduced joint deterioration (111). 
 Tendons 
Tendons are anatomic structures made of connective tissue, whose role is to connect 
muscles to bones and to transfer the force created in the former to the latter, which 
makes the joint movement possible. The tissue is built of extracellular matrix, which 
consist of collagen (mainly type I), elastin, various proteoglycans and water with the 
distinctive elongated fibroblast type cells called tenocytes, embedded between 
collagen fibres  (112). The structure of the tissue is highly organised, cross-links form 
insoluble collagen molecules, which aggregate into microfibrils and further into the 
collagen fibrils, an electron microscopically visible units. Then, a group of collagen 
fibrils builds a form called collagen fibre, which is a basic unit of tendon tissue. The 
group of collagen fibres forms a primary fibre bundle, then a bunch of primary fibre 
bundles forms a secondary fibre bundle, which in a group create a tertiary bundle. 
Finally, the tertiary bundles build up the tendon, which is surrounded by epitenon, a 


















(Reproduced from Kannus (2000) (112))  
 
The part of the tendon connecting it to the muscle is called myotendinous junction 
(MTJ), to the bone – an osteotendinous junction (OTJ) and the middle section is called 
midsubstance. Tendon tissue is not uniform over the entire length, the region of 
enthesis (insertion site) can be divided into 4 zones. First one exhibits tendon 
properties, it includes type I collagen fibres and the proteoglycan decorin; cells present 
in this part are tendon fibroblast cells only. The second zone is made-up off a non-
mineralised fibrocartilage, which is built of type II collagen and a small amount of 
type I and III collagen, as well as decorin and aggrecan. The main type of cells is 
chondrocytes. The third zone is a mineralised fibrocartilage and it includes type II and 
type X collagen and aggrecan with embedded hypertrophic chondrocytes. Finally, the 
fourth zone is bony and is composed of mineralized type I collagen (113). Healthy 
tendons are expected to be brilliant white and their texture should be fibro-elastic, 
presenting great resistance to mechanical forces (112).   
Figure 1.5. The tendon structure: from collagen fibrils to the entire tendon (details 




1.5.2.1. Hh signalling pathway in tendon development 
Multiple cell signalling pathways (e.g. bone morphogenetic protein (BMP), fibroblast 
growth factor (FGF), or transforming growth factor beta (TGFβ) signalling (114-117)) 
have been found to be involved in the development of tendons. Among them, the Hh 
signalling pathway was reported to play a crucial role in tendon-to-bone insertion site 
growth. It has been shown that most of the critical events in entheses development 
occurred at postnatal time points (118, 119).  
Liu et al. (2012) reported that in a mouse embryo at E17.5 (E – embryonic day) only 
a small number of cells at the insertion site responded to Hh ligand, which changed at 
P1 (P – post-natal day), when both, the intensity of IHC staining for antibody against 
GLI and number of cells responding significantly increased. The decrease in signal 
strength was recorded around P7, to reach a very low level at P14.  They also showed 
that the cells at the tendon-to-bone insertion respond to Hh signalling at the same time 
at which the first molecular marker of the tendon enthesis, tenascin-C appears, which 
suggested an important role for Hh signalling in tendon development (120). The same 
team in further studies investigated the role of Hh signalling in the midsubstance (121). 
They reported that the activation of Hh pathway in the midbody of the patellar tendon 
induced an expression of genes (i.e. tenascin-C and biglycan) usually expressed only 
in the enthesis(120) (to which Hh signalling is normally restricted). On the other hand, 
the loss of Hh signalling resulted in reduced chondrogenesis in the insertion site, lower 
concentration of cartilage glycosaminoglycans and elimination of the tidemark 
normally visible in H&E sections between uncalcified and calcified fibrocartilage 
layers (121). Altogether, these data suggest that the Hh signalling pathway plays a 






2. Aims and hypotheses 
The aim of the project was to verify the role of UBR5 in skeletal tissue homeostasis. 
Using a conditional Ubr5 mutant mouse our lab (Ditzel team) identified a novel role 
for UBR5 protein in maintaining AC homeostasis and suppressing OA, potentially 
through influencing the Hh signalling pathway. Based upon these in vivo observations 
I hypothesise that UBR5 utilises Hh signalling to influence the activity of a recently 
identified AC-resident mesenchymal stem/progenitor population that provides this 
tissue with a mean to both maintain/repair itself. I planned to address this hypothesis 
by investigating the chondrogenic potential of UBR5-deficient stem/progenitor cells 
in an in vitro model of chondrogenesis.  
The aim of the first part of my project is described in details below: 
Aim (1) Determine chondrogenic potential of Ubr5-deficient mesenchymal 
stem/progenitor cells (MSCs) 
Objective A. Establish an in vitro system to culture and characterise MSCs:  
 Isolate MSCs from bone marrow from wild type mice (C57BL/6 strain) 
 Establish appropriate conditions for culturing MSCs in vitro  
 Validate MSCs expression markers 
 Isolate MSCs from conditional Ubr5 mutant mice carrying tamoxifen-
inducible pCAGG-Cre-ERT2 system 
 Induce UBR5 loss using tamoxifen 
 Confirm efficient tamoxifen-mediated loss of Ubr5 expression 
 Examine cellular behaviour after tamoxifen-mediated loss of UBR5  
Objective B. Establish an in vitro system to induce chondrogenesis from MSCs: 
 Utilise chondrogenic culture conditions (Chondrogenesis Differentiation Kit) 
to drive wild type MSCs into chondrogenic lineages  
 Induce UBR5 loss in conditional Ubr5mt MSCs using tamoxifen 
 Utilise chondrogenic culture conditions to drive conditional Ubr5 mutant 
MSCs into chondrogenic lineages after tamoxifen treatment 
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The failure to isolate and culture conditional Ubr5 mutant MSCs (described in details 
in results section) made the first part of the project not feasible in the limited time 
frame of my master studies, therefore I focused on the second part of my research, 
which concerned addressing the role of UBR5 protein in tendons homeostasis. Two 
parts of the projects were related not only through UBR5 loss, but also because 
impaired tendon function could cause whole joint destabilisation, then AC damage and 
subsequently OA. 
Another role of UBR5 identified by our lab was controlling the heterotopic tendon 
ossification in the mouse limb. Using Prx1-Cre combined with a Ubr5 mutant allele 
(Ubr5mt) they deleted UBR5 function in the developing murine embryonic limb bud. 
µ-CT analysis revealed HO in Ubr5 mutant adult animals and histological analysis 
showed the presence of chondrocytes within the tendon. The conclusion was that 
UBR5 normally act to suppress heterotopic tendon ossification.  
Based on these findings I hypothesised that UBR5 regulates stem/progenitor behaviour 
to control tendon homeostasis through the activity of Hh signalling pathway, similarly 
to AC. I aimed to address this hypothesis by characterisation of the existing 
histological material collected from mice affected by ossification. 
The aim of the second part of my project is described in details below: 
Aim (2) Determine the role of UBR5 protein in tendons ossification process 
Objective A. Establish changes in tendons after UBR5 loss 
 Histological staining of limbs collected from  
o 24-weeks old UBR5-deficient (limb specific) mice (Prx1-Cre 
homozygous Ubr5 mutant animals) 
o wild type mice (C57BL/6 strain) 
 Establish cell type markers (SOX9 and RUNX2) profile in tendons using 
immunohistochemistry staining on sections from:  
o 24-weeks old UBR5-deficient (limb specific) mice (Prx1-Cre 
homozygous Ubr5 mutant animals) 




Objective B: Determine if aberrant Hedgehog signalling induces heterotopic tendon 
ossification 
 Establish Hh signalling pathway markers (IHH, GLI, PTCH1) profile in 
tendons using immunohistochemistry staining on sections from:  
o 24-weeks old UBR5-deficient (limb specific) mice (Prx1-Cre 
homozygous Ubr5 mutant animals) 
o wild type tissue (C57BL/6 strain)  
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3. Material and methods 
3.1. Animal procedures 
 Animal husbandry 
Animal studies were approved by Medical Research Council Institute of Genetics and 
Molecular Medicine ‘Animal Care and Use Committee’ (applications PL21–06 and 
PL26–11) and carried out according to guidance issued by the Medical Research 
Council in Responsibility in the Use of Animals for Medical Research (July 1993), EU 
Directive 2010 and UK Home Office Project License no PPL 60/4424. Mice had 
constant access to food and water and were maintained on 12-hour light and dark 
cycles. Pups were weaned at three weeks old at which point ear clips were collected 
for genotype analysis. Animals were sacrificed by schedule 1 methods (CO2 and 
cervical dislocation).  
 Experimental mouse strains 
Two strains of mice were used in this research: C57BL/6, later called wild type, and 
animals harbouring a flanking LoxP Ubr5 mutant conditional allele coupled with 
tissue-wide expression of tamoxifen-inducible Cre-ERT2 (122). 
Conditional Ubr5 mutant mice were generated as described (123). Briefly, mice 
carrying a flanked-loxP Ubr5 conditional gene trap (Figure 3.1.A) were crossed with 
pCAGG-Cre-ERT2 or PRX-1-Cre carrying mice, depends on the desired type of 
mutation. CreERT2 recombinases are generated by fusing Cre to mutated ligand-
binding domains (LBDs) of oestrogen receptor (ER) (without a mutation the 
recombinase could be activated by a natural, endogenous ligand). The CreER2 
recombinases stay then inactive until an exposure to synthetic oestrogen receptor 
ligand 4-OH tamoxifen (TAM), which enables an external temporal control of 
recombinase activity (122). Cre-recombinase might be driven by various promoters 
resulting in targeted gene knockout. In this case, CreERT2 was driven by two types of 
promoters: the ubiquitous CAGG promoter (124) and limb specific Prx1(125) 
promoter. EUCOMM EUCE0171f01 Ubr5 conditional gene trap inserted between 
exons 20 and 21 (Figure 3.1.A) was used to interfere with Ubr5 mRNA expression and 
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as a consequence with UBR5 protein function. Depending on the action of FLP-and 
Cre-recombinases gene trap could exist in three distinct states (126) (Figure 3.1.B): (i) 
without the recombinase the gene trap resided in the mutagenic orientation (Ubr5mt); 
(ii) after FLP-mediated recombination, in the non-mutagenic orientation (Ubr5WT*); 
and (iii) after Cre-mediated recombination, in the mutagenic orientation (Ubr5mt*). 
When the gene trap is in the mutagenic orientation the expected fusion protein consists 
of UBR5’s N-terminal UBA domain combined with a β-galactosidase-neomycin 
phosphotransferase fusion protein (βGEO). The addition of βGEO confers protein with 
both beta-galactosidase activity and neomycin resistance. Such a fusion called 
UBR5mt, was expected not to be active due to the lack of several domains and their 
crucial functions: (i) E3 activity through loss of the C-terminal catalytic HECT domain 
(127), (ii) N-end rule function due to loss of the UBR domain (128) and (iii) miRNA 
regulatory function because of the absence of its poly(A)-binding protein C-terminal 
(PABC) domain (129). 
The combination of the Cre-lox system and gene trapping has provided a means to 
achieve conditional gene knockout through differential application of TAM or only in 




   
Figure 3.1. The Ubr5 gene trap and mechanism of gene inactivation.  
(A) Schematic representation of the EUCOMM EUCE0171f01 gene trap introduced 
in between exons 20 and 21 of the murine Ubr5 gene. It consists of promoterless 
reporter gene (lacZ encoding β-galactosidase) and neomycin-resistance gene (neo) 
combined into fusion gene called βgeo, flanked by an upstream splice acceptor (SA) 
site and a downstream polyadenylation signal (pA). Flanking recombination sites, 
FRT, F3, loxP and lox511, provide conditionality by FLP-mediated (FRT and F3) 
inversion and Cre-mediated (lox511 and loxP) re-inversion. (B) Schematic illustration 
of the effects of FLP and Cre-mediated recombination on the gene trap and UBR5 
protein/domain expression. The gene trap can exist in three distinct states: (i) in the 
absence of recombinase the gene trap stays in the mutagenic orientation (Ubr5mt); (ii) 
after FLP-mediated recombination, it is inverted in the non-mutagenic orientation 
(Ubr5WT*); and (iii) after CRE-mediated recombination (for pCAGG-Cre-ERT2 
induced by TAM treatment), it is once again in the mutagenic orientation (Ubr5mt*). 
UBA, UBR, PABC and HECT – domains present in UBR5 protein 
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 Mouse genotyping 
Genomic DNA was extracted from adult mouse ear clips using alkaline-lysis based 
extraction (130). The material was digested in 75µl lysis buffer (25 mM NaOH, 0.2 
mM disodium EDTA, pH 12) by heating for 30 minutes at 95°C, followed by cooling 
to 4°C. The sample was then mixed with 75µl neutralisation buffer (40 mM Tris-HCl, 
pH5) and used in PCR-based genotyping reactions with pre-mixed polymerase 
(Bioline MyTaq Red). PCR products were run on a 3% agarose gels (in TBE buffer) 
containing GelRed™ Nucleic Acid Gel Stain (Biotium) and visualised under UV light. 
The sequences of primers designed to detect various alleles, their expected product 
sizes and cycling conditions used are detailed below (Table 3.1). Forward primers are 
labelled as FP and reverse primers as RP.  
 
Table 3.1. Primer sequences and product sizes of primers used for mouse 
genotyping 







FP – GCCTTCTGTAATTCGTAGTCCC 




FP – CGCGAAGAGTTTGTCCTCAC 




FP – GCATTACCGGTCGATGCAACGAGTGATGAG 






3.2. Molecular biology techniques 
 RNA extraction 
RNA was extracted from cells using a QIAshredder ® homogenizer (Qiagen) coupled 
with an RNeasy ® Mini Kit (Qiagen) as per manufacturer’s instructions. Briefly, the 
extraction process involved the lysis of cells using a denaturing guanidine thiocyanate 
buffer. The lysate was then loaded onto a QIAshredder ® column and centrifuged to 
homogenize it and to remove insoluble material. Next, ethanol was added to provide 
appropriate binding conditions. The sample was then applied to an RNeasy Mini spin 
column containing a silica-based membrane and centrifuged. The total RNA bound to 
the membrane and the contaminants were removed using a wash buffer. Finally, the 
RNA was eluted in an appropriate volume of water (30-50µl). The quantity of RNA 
sample was checked using NanoDrop ® ND-1000 spectrophotometer (Thermo 
Scientific). For part of the experiments RNA underwent a DNase treatment using 
RNase-Free DNase Set (Roche) following manufacturer’s manual. 
 First strand complimentary DNA (cDNA) synthesis 
cDNA was generated using a First Strand cDNA Synthesis Kit for RT-PCR (AMV) 
(Roche) as per manufacturer’s instructions, utilizing either oligo(dT)15 primers or 
sequence-specific primers, with between 150ng and 1µg RNA used per reaction, 
depending on the amount available. Briefly, this process involved the generation of a 
cDNA template using mRNA isolated from murine cells. Most of the components were 
the same as for a normal PCR (Table 3.2); however, it required the use of a reverse 
transcriptase instead of polymerase. While polymerases replicate complementary 
DNA strands, reverse transcriptase uses an RNA template to produce complementary 








Table 3.2. Reagents for cDNA synthesis  
Reagent Volume Final conc. 
10x Reaction Buffer 2.0 µl 1x 
25mM MgCl2 4.0 µl 5mM 
Deoxynucleotide Mix 2.0 µl 1mM 
Oligo(dT)15 primer 2.0 µl 1.6µg 
RNase Inhibitor 1.0 µl 50U 
AMV Reverse Transcriptase  0.8 µl ≥20U 
Water (PCR grade) Variable - 
RNA sample Variable - 
Total 20 µl  
 
 
Table 3.3. Conditions for cDNA synthesis  
Step Temperature (°C) Time Cycles 
Primer annealing 25 10 1 
Reverse transcription 42 60 1 
 
 Semi-quantitative gene expression analysis (RT-PCR) 
Semi-quantitative RT-PCR was performed using a BIOTAQ DNA Polymerase kit 
(Bioline) with 2µl of cDNA used per reaction. β-actin was used as a loading control. 
Gene specific primers used are listed in Table 3.4. Forward primers are labelled as FP 
and reverse primers as RP. Reaction conditions were as per table 3.5. PCR products 
were run on a 3% agarose gels (in TBE buffer) containing GelRed™ Nucleic Acid Gel 






Table 3.4. Primer sequences and product sizes of primers used for RT-PCR 
Allele Sequence (5’-3’) Tm (°C) 
Product 
size (bp) 
MSCs POSITIVE MARKERS 
CD29 
FP – CAACCACAACAGCTGCTTCTAA 





FP – ATGAACATCCTGGGCTACGA 
RP – GTCCTTCCACACCGTTATCAA 
55 67 
CD105 
FP – CGTTCTCTTCCTGGATTTTCC 
RP – ATTTTGCTTGGATGCCTGAA 
53 70 
MSCs NEGATIVE MARKERS 
CD11b 
FP – CAATAGCCAGCCTCAGTGC 





FP – GGGTAGCTCTCTGCCTGATG 





FP – CGGGATGAGACAGTTGATGA 






FP – TGTACTGGATCAATCCCACTCTAA 
RP – TTTTCACTGGTAGGAAAGTGAAGA 
55 91 
Scx 
FP – ATGTCCTTCGCCATGCTG 
RP – GCTCACCTCAGGGTACAGGTA 




FP – AGTTTCAGCTTTGTGGACCTC 






FP – GGCCCAGAGCAAGAGAGGTATCC 
RP – ACGCACGATTTCCCTCTCAGC 
55 460 
Ubr5 
FP – TCAGCTCGAAGAGAGAGGATG 









Table 3.5. Typical cycling conditions for RT-PCR 
Step Temperature (°C) Time (min:sec) Cycles 
Initial Denaturation 94 2:00 - 
Denaturation 94 0:30  
      x30 Annealing 55 0:30 
Extension 72 0:30 
Final Extension 72 1:00 - 
 
 Quantitative gene expression analysis (qRT-PCR) 
Quantitative RT-PCR (qRT-PCR) was performed using either the StepOnePlus™ 
Real-Time PCR (Applied Biosystems) or the Lightcycler ® 480 instrument (Roche) to 
check the expression of a gene of interest (GOI) relative to a housekeeping gene. Gene 
specific assays were designed using the online Universal Probe Library Assay Design 
Centre on the Roche Applied Science website (www.universalprobelibrary.com). Each 
analysed gene requires a specific primer pair and a hydrolysis probe. The hydrolysis 
probe for the gene of interest is labelled at the 5’ end with reporter fluorophore 
(fluorescein, FAM) and at the 3’ with a dark quencher dye, while the probe for the 
reference gene is labelled at the 5’ end with Lightcycler ® Yellow 555 and at the 3’ 
end with a dark quencher dye. When the probe is intact, the quencher and the 
fluorophore are close enough for the quencher to inhibit fluorescent emission. If the 
target sequence is present, the probe anneals downstream from one of the primer sites. 
However, during the extension step of PCR reaction, the Taq DNA polymerase cleaves 
the probe thanks to its 5’ nuclease activity, causing the separation of the fluorophore 
and the quencher. The cleavage results in the emission of fluorescent signal. More 
reporter fluorophore molecules are cleaved from the probes with every cycle which 
causes an increase in fluorescence intensity proportional to the amount of generated 





Table 3.6. Summary of primers pairs and Universal Probe library probes used for 
quantitative RT-PCR analysis 
Allele Sequence (5’-3’) Probe 
Actb 
FP – AAGGCCAACCGTGAAAAGAT 
RP – GTGGTACGACCAGAGGCATAC 
# 56 
Ubr5 
FP – TCAGCTCGAAGAGAGAGGATG 
RP – GCTCAGCAATGTAGCACGTC 
# 103 
 
Each reaction contained Lightcycler ® Probes Master ready-to-use reaction mix, target 
gene primers and probe, GAPDH primer mix and probe, activator, enhancer and water 
(Table 3.7).  
Table 3.7. Reagents for one step qRT-PCR (GOI – gene of interest)  
Reagent Volume Final conc. 
Water (PCR grade) 4.3 µl - 
Primer/Probe, 10x (GAPDH) 2.0 µl 0.5 µM/0,25 µM 
Primer/Probe, 10x (GOI) 2.0 µl 0.5 µM/0,25 µM 
Activator 1.3 µl 3.25mM 
LightCycler® 480 RNA Master 
Hydrolysis Probes, 2,7x 
7.4 µl 1x 
Enhancer, 20x 1.0 µl 1x 
RNA sample 2.0 µl - 
Total 20 µl  
 
Reactions were prepared in triplicate in 96-well plastic PCR plates. Plates were 
covered with sealing foil and held on ice until ready to be loaded into a StepOnePlus™ 
Real-Time PCR or Lightcycler ® 480 II Instrument and analysed using the cycling 





Table 3.8. Typical cycling conditions for qRT-PCR 
Step Temperature (°C) Time (min:sec) Cycles 
Reverse 
Transcription 
63 3:00  - 
Initial Denaturation 95 10:00 - 
Denaturation 95 0:15  
      x45 Annealing 60 0:60 
Extension 72 0:05 
Cooling 40 1:00 - 
 
Data were analysed by relative quantification using StepOne Software (Version 2.3) 
and Lightcycler ® 480 Software (Version 1.5). Ct values for Ubr5 in TAM-treated 
cells were normalised to the reference gene (GAPDH). The fold change in gene 
expression relative to that in the control cells was then calculated using a comparative 
Ct method, based on following arithmetic formula: 2-∆∆Ct (131), where ∆∆Ct = (CT, 
GOI - CT, GAPDH)TREATED CELLS – (CT, GOI - CT, GAPDH)CONTROL CELLS. The result of this 
equation is the amount of target, which is normalised to an endogenous reference gene 




3.3. Cell culture 
 Isolation of murine mesenchymal stem/progenitor cells from bone 
marrow 
Murine mesenchymal stem/progenitor cells (MSCs) were obtained by isolating bone 
marrow from the long bones from 8-10 weeks old mice (wildtype C57BL/6 or 
conditional Ubr5mt pCAGG-Cre-ERT2 carrying mice). After the mice were sacrificed, 
the hind limbs were removed and transferred in ice-cold PBS (or medium if time 
between dissection and cell isolation was prolonged). Soft tissue was removed from 
the long bones. The clean bones were placed into α-MEM medium supplemented with 
10% FCS, 100U/ml Penicillin, 100μg/ml Streptomycin, 2mM glutamine (called later 
culture medium). The epiphyses of the bones were cut off and bone marrow was 
flushed out using a 25G needle. The marrow containing medium was spun at 300g, for 
3 minutes to pellet the cells, then re-suspended in culture medium, plated into a Petri 
dish and incubated at 37ºC, 5% CO2 for 24 or 72 hours (3 mice divided between 2 x 
10cm Petri dishes). After initial incubation (24 or 72h) time, all non-adherent cells 
were discarded and the plate surface washed with PBS (Figure 3.2).  
   
Figure 3.2. Scheme of MSCs isolation.  
Animal were sacrificed at 8-10 week of age, both femurs and tibiae were dissected. 
Epiphyses of the bones were cut off and bone marrow was flushed out. Cells were spun 
down, supernatant was removed, pellet was re-suspended in culture medium and plated 
on a Petri dish. After 3 days of incubations medium was discarded and adherent cells 
were kept for further studies. 












Medium was replaced every 2-3 days. When 60-70% confluent (based on microscopic 
observation), cells were removed from the dish by incubation with 0,05% 
trypsin/EDTA (Gibco) for 2 minutes at 37ºC and gentle scraping. Cells were then 
plated once again and kept in culture for 15 days before they were used for further 
experiments. The MSCs nature of isolated cells was confirmed by using RT-PCR to 
check the expression of positive (CD29, CD73, CD105) and negative (CD11b, CD34, 
CD45) MSCs markers. 
MSCs isolated from conditional Ubr5mt pCAGG-Cre-ERT2 carrying mice were 
treated with TAM (concentration range – 0,1-5µM, incubation time range – 24-96h) 
to induce mutation of Ubr5 gene. The viability of the cells was determined using 
trypan blue staining by detecting the absence/presence of cell staining. This technique 
is based on the principle that viable cells have intact cell membranes, which protect 
them from taking up certain dyes, such as trypan blue, whereas dead cells stain dark 
blue because of the stain uptake (132). 
 Chondrogenic differentiation  
High-density cell culture is important for the chondrogenic differentiation of MSCs, 
as it mimics development of cartilage in the embryonic limb bud (133, 134) and 
promotes cellular condensation (135, 136). Mesenchymal precursors seeded in low-
density adopt features of a fibroblast and they lose the ability to differentiate (137). 
This indicates that a high-density is necessary to induce a specific ECM formation. 
The ECM may have both direct and indirect influence on cells modulating their 
behaviour.  
Two high-density culture systems, micromass and pellet culture, were used to trigger 
chondrogenesis in my research. The differentiation was supported by usage of special 
chondrogenic kits with serum-free medium containing various growth factors (e.g. 
TGF-β1 (138)).  
3.3.2.1. Chondrogenic differentiation – micromass culture 
Chondrogenic differentiation in micromass culture was performed using StemPro® 
Chondrogenesis Differentiation Kit (Gibco) according to manufacturer’s protocol. 
Briefly, on day 15, MSCs cultures were washed with PBS, treated with 0,05% 
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trypsin/EDTA (Gibco) for 2 minutes followed by neutralisation with culture medium 
and scraped gently to detach adherent cells from a culture surface. They were spun 
down at 300g for 5 minutes, the supernatant was discarded and cells were resuspended 
in fresh culture medium. Micromass cultures were generated by plating 20, 50 and 
80µl droplets of the cell solution at a density of 1,6x107 cells/ml on 24-well plate. The 
neighbouring wells were filled with PBS to prevent the droplets dehydration. Cells 
were incubated in 37°C for 2 hours under high humidity condition, followed by 
addition of 500μl of StemPro® Chondrogenesis Differentiation medium (Gibco) – a 
commercial, serum-free chondrogenic induction medium. One droplet of 20µl was 
incubated in MSCs culture medium as a control.  Micromasses were cultured for 18 
days with medium change every 2-3 days. The differentiation of the cells was 
determined by histology staining. 
3.3.2.2. Chondrogenic differentiation – pellet culture 
Chondrogenic differentiation in pellet culture was performed using HyClone™ 
AdvanceSTEM™ Chondrogenic Differentiation Medium (GE Healthcare Life 
Sciences) according to manufacturer’s protocol. Briefly, on the day 15, MSCs culture 
was washed with PBS, treated with 0,05% trypsin/EDTA (Gibco) for 2 minutes 
followed by neutralisation with culture medium and scraped gently to detach adherent 
cells from a culture surface. 1x106 cells were spun down at 200g for 10 minutes in 15-
ml polypropylene conical tubes, the supernatant was gently removed and 4ml of 
chondrogenic differentiation medium was added carefully on the top of the pellet, to 
not to disturb or resuspend it in solution. The control pellet was incubated in MSCs 
culture medium. The caps on the tubes were slightly loosened for gas exchange. The 
pellet cultures were incubated at 37°C and 5% CO2 for 21 days. Medium was carefully 
replaced every 3 days avoiding disturbance of the pellet. The differentiation of the 




3.4. Histological analysis 
 Tissue collection and processing 
Tissue samples for histological analysis were collected from 8-10 weeks old wild type 
mice. The animals were first sacrificed, then hind limbs were dissected and fixed for 
72hrs at 4°C in 4% paraformaldehyde (PFA) (Cambridge BioScience). Prior to 
paraffin wax embedding, samples were washed in PBS and decalcified at room 
temperature in 10% EDTA (Sigma, E9884) for seven days. Complete decalcification 
was confirmed by µCT scanning. Hind limbs were divided to separate knee joint from 
foot (cut above the Achilles tendon) and every part was individually embedded in 
paraffin wax. The embedded tissue was then sectioned in sagittal orientation at 5μm 
on a microtome (Leica RM2235) and mounted on SuperFrost ® slides (Thermo 
Scientific). To proceed with further studies every ten sections was de-waxed, stained 
using standard histological techniques for haematoxylin and eosin staining and utilised 
as a set of guide slides to facilitate the choice of sections both in correct orientation 
and with visible patellar/Achilles tendon for immunohistochemistry (IHC).  
 Immunohistochemistry 
Chosen sections were dewaxed in xylene twice for 5 minutes followed by rehydration 
through a descending series of ethanol washes (100%, 80%, 50%) for 5 minutes each 
in a plastic slide rack. Endogenous peroxidase was blocked by incubation in 3% 
hydrogen peroxide water solution for 20 minutes. For heat-based antigen retrieval, 
slides were transferred to coplin jar filled with 10mM sodium citrate (in ddH2O, pH6) 
and placed into 80°C water bath for 40 minutes. Slides were left in the citrate buffer 
to cool at room temperature for 30 minutes followed by series of three washes in PBS 
buffer with Tween (PBS-T, 0,05%). Using a hydrophobic barrier pen (ImmEdge pen, 
Vector), the sample region was circled to keep reagents within a targeted area. All 
epitopes on the tissue sample were blocked to prevent the nonspecific binding of the 
antibodies by incubation with protein blocking reagent (type depended on the 
experiment) for 30 minutes in room temperature. Primary antibody was then applied 
on the slides and incubated overnight at 4°C. Antibodies and used dilutions are listed 




Table 3.9. Summary of primary and secondary antibodies used for IHC 




anti-PTCH1 Goat 1:50 200µg/ml 
G-19,  
Santa Cruz 
Anti-GLI1 Rabbit 1:50 N/A 
V812, 
Cell Signalling 
Anti-IHH Rabbit 1:200 200µg/ml 
H-88, 
Santa Cruz 
Anti-EDD1 Rabbit 1:250 1mg/ml 
A300-573A, 
Bethyl Labs 















After series of three washes in PBS-T (0,05%) buffer sections were incubated with 
appropriate biotinylated secondary antibody (table 3.9) for 45 minutes at room 
temperature. Another three PBS-T (0,05%) washes were carried out prior to 
streptavidin-mediated signal amplification using an ABC kit (Vector Labs) as per 
manufacturer’s instructions. After 30 minutes of incubation in the dark, slides were 
washed three times in PBS-T (0,05%) buffer followed by antibody binding 
visualisation using DAB (3,3'-diaminobenzidine) Peroxidase substrate kit (Vector 
Labs) as per manufacturer’s protocol. The incubation times were consistent for antigen 
analysis across samples, but they varied for each individual antigen (2-10 minutes). 
Sections were then dehydrated through an ascending series of ethanol washes (50%, 
80%, 100% x 2) for 30 second each before clearing in xylene twice, for 1 and 5 
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minutes, mounted using DPX (Merck) in the fume hood and left to dry overnight 
before further analysis.  
 Histological analysis of micromass culture 
Chondrogenic differentiation in micromass culture was verified by toluidine blue (TB) 
staining according to the protocol provided by Helen Caldwell from the Division of 
Pathology (University of Edinburgh). After 18 days of chondrogenic stimulation cells 
were washed carefully with PBS avoiding disruption of the micromass, fixed for 30 
minutes at 4°C in 4% PFA (Cambridge BioScience) followed by another washing with 
PBS. TB reagent (0.05%, ethanol and water solution) was added to every well and 
incubate for 3 minutes. After triple washing with PBS the results of staining were 
checked under the microscope.  
 Histological analysis of pellet culture 
After 21 days of chondrogenic stimulation the pellet was washed carefully with PBS 
avoiding disruption of the aggregate, fixed for 1h at 4°C in 4% PFA (Cambridge 
BioScience), dehydrated and embedded in paraffin. It was then sectioned with a 
thickness of 5 µm on a microtome (Leica RM2235) and mounted on SuperFrost ® 
slides (Thermo Scientific). Sections were dewaxed and stained using standard 
histological procedures with haematoxylin and eosin (Sigma) to visualize the cell 
morphology and with toluidine blue (Sigma) to visualize the proteoglycan content in 
the pellet (139, 140). 
 Slide Imaging 
Histology and IHC slides were imaged using Hamamatsu NanoZoomer-XR slide 
scanner with 40x magnification and analysed using Hamamatsu NDP.view 2.4 
software. 
 β-Galactosidase Staining 
The efficiency of Ubr5 mutation in TAM-treated pCAGG-Cre-ERT2 carrying MSCs 
was verified by determination of β-galactosidase expression after treatment.  
β-galactosidase staining was performed using β-galactosidase Staining Kit (Mirus) 
according to manufacturer’s protocol. Briefly, after 4 days of TAM-treatment cells 
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were washed with PBS, fixed for 30 minutes at 4°C in 4% PFA (Cambridge 
BioScience) followed by another washing with PBS. Cell Staining Working Solution 
(Mirus) was mixed with X-Gal Reagent (Mirus) and added to every well (200μl per 
well for 96-well plate). Plate was covered in foil to protect it from light and incubated 
overnight at 37°C. Next morning cells were washed 3 times with PBS and the 




4.1. Establishment of an in vitro system to culture and 
characterise mesenchymal stem cells 
Using a conditional Ubr5mt mouse the Ditzel lab identified a novel role for the 
ubiquitin-protein ligase UBR5 in maintaining AC homeostasis and suppressing OA, 
potentially through influencing the Hh signalling pathway. Based upon these in vivo 
observations I hypothesise that UBR5 utilises Hh signalling to influence the activity 
of an AC-resident stem/progenitor population that provides this tissue with a mean to 
maintain/repair itself. I aimed to address this hypothesis by investigating the 
chondrogenic potential of UBR5-deficient stem/progenitor cells in an in vitro model 
of chondrogenesis. Generation of an in-vitro cell-based model would provide us with 
a tool to easily modulate the Hh signalling pathway and monitor chondrogenesis, all 
without a need for expensive and time-consuming mouse experiments. 
 Cell isolation from C57BL/6 (wild type) animals 
4.1.1.1. Optimisation of initial bone marrow incubation 
24h of initial bone marrow incubation 
The first objective was to establish optimal conditions for the isolation and culture of 
murine MSCs from bone marrow.  
The protocol was provided by Dr Antonia Sophocleous from Centre for Genomic and 
Experimental Medicine (University of Edinburgh) and was based on the criteria for 
MSCs proposed by International Society for Cellular Therapy (ISCT). These criteria 
state that MSCs should (i) be plastic-adherent when cultured in standard conditions, 
(ii) must express specific group of surface markers dependent on the cell source and 
(iii) have the capacity to differentiate into chondrocytes, adipocytes or osteocytes 
(141). 
Optimisation was perform using bone marrow collected from three 8-10 weeks old 
wild type C57BL/6 mice. When choosing the age of animal, I took into consideration 
that the population of stem cells in bone marrow decreases with age, however long 
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bones from very young mice are very small and fragile and can prove difficult to 
handle. Bone marrow was flushed from 6 femurs and 6 tibias, pooled and passed 
through the needles of decreasing size to homogenize. The homogenate was 
centrifuged and the pellet resuspended in fresh culture medium. Bone marrow 
suspension (BMS) was divided and incubated for 24hrs in two 10cm tissue culture 
plates. Non-adherent cells were then discarded and the bone-marrow derived adherent 
cells (BMACs) kept in culture for two weeks. The majority of the cells remained in 
discarded suspension with only a few rounded cells remaining attached to the plastic 
surface of a Petri dish (Figure 4.1.A). After 5 days of incubation the BMACs changed 
morphology from rounded into spindle-shaped-like (Figure 4.1.B). After 15 days, the 
BMACs reached less than 5% confluency and there appeared to be no signs of further 












In conclusion, the isolation of adherent cells from bone marrow was successful, 
however the yield of cells was low. One reason may have been the low number of 
adherent BMACs in the initial step. I therefore decided to modify the isolation method 
and extend the initial bone marrow incubation time to check if this allows more cells 
to adhere to the culture dish. 
 
Figure 4.1. Murine bone marrow cells adhere and spread out on plastic.  
(A-C) Representative fields showing bone marrow-derived cells morphologies 
following incubation on plastic. (A) After 24hrs, only a few round-shaped attached to 
the plastic surface of a Petri dish. (B) After 5 days of incubation the adherent round 
cells changed into flatter cells with extended processes. (C) After 15 days, the numbers 
cells did not increase and existing cells enlarged. Images taken at x10 magnification; 
scale bar: 50µm  
A B C 
24h 5d 15d 
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72h of initial bone marrow incubation.  
In an attempt to increase the yield of BMACs I decided to increase the duration of the 
initial incubation to 3 days (142). I predicted that extending the time for cell adherence 
would recover more bone marrow-derived adherent cells. After 48hrs I observed 
significantly more cells had attached than at 24hrs (Figure 4.2.A). Another 24hrs of 
incubation period allowed the adherent cells to cover 30-40% of a 10cm plate (Figure 
4.2.B). This was in contrast to the 1-2% adherent BMACs following an 24hr 
incubation. After 48hr incubation, most of the isolated BMACs were elongated and 
exhibited a spindle-shape (Figure 4.2.C). BMACs were first passaged upon reaching 
60% confluency (approx. 72hrs post isolation). It was important to avoid >80% culture 












Increasing the initial bone marrow incubation time to 72h allowed more cells to adhere 
to plastic dish and, consequently, increased the yield of BMACs obtained after 2 weeks 
of culturing.  
Figure 4.2. (A) Total bone marrow suspension and (B, C) bone marrow-derived 
cells adhered on plastic.  
Representative fields showing bone marrow-derived cells morphologies. (A) 48h after 
isolation, before bone marrow suspension was removed, some of the cells remained in 
suspension with plenty of round-shaped cells attached to the plastic surface of a Petri 
dish. (B) On Day 3 bone marrow suspension with non-adherent cells were discarded. 
The adherent cells contained both round and spindle-shaped cell. (C) On Day 4, cell 
confluency reached approx. 60-70% and the numbers of spindle-shaped cells were 
increased. Images taken at x10 magnification; scale bar: 50µm 
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4.1.1.2. Mesenchymal stem cell characterisation 
Mesenchymal stem cells markers  
According to minimal criteria for MSCs proposed by International Society for Cellular 
Therapy (ISCT), MSCs must express group of surface markers. Of that group, I chose 
the 3 most frequently assessed positive markers for murine MSCs – CD29, CD73 and 
CD105 (141, 145). Additionally, these cells should lack expression of markers 
characteristic for hematopoietic cells. Accordingly, I chose 3 of the most frequently 
assessed negative markers - CD11b (monocyte/macrophage-associated), CD34 
(hematopoietic-associated) and CD45 (leukocyte-associated) (141).  
Cells from 4-days old BMAC culture were used to isolate RNA to check the expression 
of MSCs surface markers with RT-PCR. Based on the presence of a signal of the 
expected size all three MSCs markers were present (Figure 4.3.A). However, three of 
the hematopoietic cell markers were also detected, which suggested the BMACs 
contains a mixture of MSC and HSCs. According to previous findings for some species 
(mice included) isolation of MSCs can be difficult due to the unwanted growth of non-
mesenchymal cells in both primary and passaged cultures (146). This might explain 
why part of cells isolated using plastic-adherence criterion was positive for 





Figure 4.3. RT-PCR analysis of positive and negative MSCs markers expression 
in bone marrow-derived adherent cells.  
Expression of (A) positive and (B) negative MSCs surface markers in bone marrow-
derived murine adherent cells by RT- PCR. (A) Expression of positive MSCs markers 
CD29, CD73 and CD105. (B) Expression of markers that should not be expressed in 
MSCs – CD11b, CD34 and CD45. Three conditions were used for analysis of all 
markers (i) the experimental reaction conditions including reverse transcriptase (RT) 
and oligo(dT) primers, (ii) without RT but with oligo(dT) primers and (iii) with water 
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Morphological characterisation of isolated cells 
Beside the expression of mesenchymal cell markers, stem/progenitor cells should 
maintain the ability to proliferate in vitro (147, 148). To check this, I documented cell 
morphology and plate confluence by taking photos every day. The BMACs were kept 
in culture and passaged 1:2 every 4 days. During the early stages (days 5-8) BMACs 
continued dividing and kept their spindle-shaped morphology. By day 8, cells with 
enlarged and flattened morphology were first detected (Figure 4.4.A). During the mid-
stages (9-12) cells continued to proliferate and, by day 12, required splitting as they 
reached 60% confluency (Figure 4.4.B). An increase in the number of flat, senescent-
like cells (SLCs) was significant – increasing from 11% of the population at day 8 to 
37% by day 12. In the late stage of culture, the proliferation rate appeared to slow 
down (Figure 4.4.C), but the percentage of flat cells did not seem to increase and stayed 
around 35%.  
According to my observations isolated cells exhibited the ability to proliferate during 
the early and mid-stages of culture. The cell division of the entire population appeared 
to slow down and coincided with an increase in SLCs. In conclusion, mid-stage 
BMACs (days 9-12) harbouring fewer SLCs and would be preferable for use in any 





Figure 4.4. Bone marrow-derived cells adhere, proliferate and potentially senesce.  
Representative fields showing bone marrow-derived adherent cells morphologies 
during (A) passage-1 (days 5-8), (B) -2 (days 9-12) and (C) -3 (days 13-18). (A, B) By 
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Chondrogenic differentiation assay 
The isolated BMACs had satisfied two of the ISCT’s MSC criteria. I next addressed 
the third, by determining their capacity for differentiation into chondrocytes. Two 
different and well-established high-density cell culture systems were used, namely 
droplet-based micromass (149) and centrifugation-mediated pellet culture (138).  
Chondrogenic differentiation in micromass culture 
For the first chondrogenic differentiation assay, BMACs were plated as a droplet at a 
high cell concentration (1,6x107 cells/ml). A range of droplet volumes were assessed 
(20, 50 and 80µl drops of the cell suspension) on 24-well plate.5 After 2h hours, the 
cells had adhered to one another and formed a micromass (Figure 4.5.A.1, 4.5.B.1). 
Micromasses were then exposed to chondrogenic, or normal, media for 18 days. Over 
time, micromass formed from 20 and 50µl droplets dispersed, however the one 
generated from 80µl droplet remained partially intact (Figure 4.5.A).  The cells in 
control medium spread and formed a monolayer culture (Figure 4.5.B). By the end of 
chondrogenic induction cells were fixed in 4% paraformaldehyde. Staining with 
Toluidine Blue (TB), a histological stain that reacts with extracellular proteoglycan 
(139, 140), confirmed BMAC cells had produced chondrocyte-associated ECM. The 
staining of the micromass cultured in chondrogenic medium indicated the presence of 
proteoglycans, which are characteristic for ECM synthesised by chondrocytes (Figure 
4.5.A.4). Culture in control medium did not show any blue staining with toluidine blue 
(Figure 4.5.B.4). 
In conclusion, these resulted suggested that BMAC cells most likely consisted of 
MSCs that underwent chondrogenesis to produce TB-reactive material.  
  
(A) By day 8 the first cells with enlarged and flattened morphologies (red arrow) 
appeared and represented 11% of the population. (B) By day 12 the percentage of 
potentially senescent cells increased to ~37%. (C) By day 15 cell proliferation 
appeared to cease and the percentage of flat cells remained the same. (D) Graphs show 
the changes in percentage of various type of cells in bone marrow-derived adherent 


























Chondrogenic differentiation in pellet culture 
For the second chondrogenic differentiation assay, high density BMACs suspension 
(1x106 cells per pellet) was transferred to two 15ml conical tube and centrifuged to 
form a pellet. Cells were cultures either in chondrogenic (with TGF-β1 as a growth 
factor ((138, 150, 151) or in control medium for 21 days.  
A.  
B.  
Figure 4.5. Micromass-based chondrogenic differentiation assay.  
Representative fields showing bone marrow-derived adherent cells morphologies in 
micromass over time. Micromass cultures in (A1-3) chondrogenic and (B1-3) non-
chondrogenic control medium. (A) Cells in chondrogenic medium aggregated and 
developed into round or oval phenotype (A3). (B) Cells in control medium revert to 
normal monolayer cell morphologies, with spindle-shaped cells (B3). (A4, B4) 
Toluidine blue staining of micromass after 18 days in culture. Figure A4 shows dark 
blue/purple staining of micromass, which suggests the presence of extracellular matrix 
secreted by chondrocytes. Culture in control medium did not show any blue staining. 
Images (A1-3, B1-3) taken at x20 magnification; scale bar: 25µm; (A4, B4) taken at 






















Figure 4.6. shows macroscopic observation of changes in both pellet cultures over the 























Figure 4.6. Pellet-based chondrogenic differentiation assay.  
(A) Early stage of chondrogenesis, after 4 days in culture the centrifuged cells formed 
a spherical aggregate at the bottom of the tube (blue circle). Cells cultured in normal 
medium did not form the aggregate (red circle). (B) Mid stage of chondrogenesis, 
pellet in chondrogenic medium stayed intact. After 8 days of chondrogenesis assay 
most of the cells in control medium dispersed (red circle). (C) Late stage of 
chondrogenesis, cells in chondrogenic medium remained in the pellet until the end of 
the differentiation assay. After 3 weeks of incubation the rest of the cells in control 
medium disappeared (red circle).  Ch – chondrogenesis assay, Control – cells treated 


















In an early stage of chondrogenesis, after 3-4 days in culture, the BMACs formed a 
spherical aggregate at the bottom of the tube (Figure 4.6.A, right). Cells cultured in a 
control medium did not form the aggregate (Figure 4.6.A, left). At day 8, the pellet 
exposed to chondrogenic medium stayed intact, whereas it was dispersed in the control 
medium (Figure 4.6.B). Macroscopic observation of the late stage of the differentiation 
assay shows that cells in chondrogenic medium remained aggregated until the end of 
the differentiation assay (Figure 4.6.C). The cell pellet in the control media dispersed 
completely upon medium change after 3 weeks of incubation. A lack of ECM secretion 
by undifferentiated cells could be a potential explanation as to why control pellet 
dispersed. Cell-cell and cell-ECM interactions within a micromass keep pellet intact 
and increase its resistance to the physical forces generated by a change of media (137).  
Beside macroscopic observations, the pellet from the chondrogenic medium was 
sectioned and stained with H&E and TB (Figure 4.7). Staining with TB supported the 







   
A. H&E staining 
B. Toluidine Blue staining 
Figure 4.7. Histological staining of sections of the pellet treated with chondrogenic 
medium.  
Section stained with H&E (A) and toluidine blue (B) after 21 days in culture. Figure 
B shows blue staining of a pellet section, which might suggest the presence of 
extracellular matrix secreted by chondrocytes. Images taken at x20 magnification; 
scale bar: 50µm 
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 Cell isolation from conditional Ubr5 mutant mice carrying tamoxifen-
inducible pCAGG-Cre-ERT2 system 
4.1.2.1. BMAC isolation and culture. Morphological characterisation of 
isolated cells 
Once I was confident about the isolation and culture of wild type MSCs I started 
working with conditional Ubr5mt primary MSCs also carrying TAM-inducible 
pCAGG-Cre-ERT2 system.  
The first studies were carried out in the absence of TAM to prevent any potential 
complications associated with Cre-mediated recombination. Relative to wild-type 
(WT) BMACs, pCAGG-Cre expressing BMACs took considerably more time to 
adhere. It took approx. 4 days for WT BMACs to achieve 60% confluency, whereas 
for Cre-expressing BMACs took 10 days to reach the same degree of confluency.  
Medium with bone marrow-derived non-adherent cells from pCAGG-Cre carrying 
mice was changed on day 8 (in comparison to WT culture where medium was changed 
after 72h) and first cells with large, flattened, senescence-like morphology were 
revealed after being washed with PBS (data not shown). Their number increased over 
time and accounted for approximately 15% of the cell population on day 10 (Figure 
4.8.D). At this stage, cells were split for the first time and reached 70% confluency. 
On day 16, the culture reached 60% confluency and cells were split once again. At that 
time 30% of the cell population exhibited the senescence-like morphology (Figure 
4.8.D), By day 20 the percentage of SLC (define at first instance as senescent-like-
cells) cells increased to 72% and no further proliferation was noticed. The graph shown 
in figure 4.8.D presents the changes in percentage of spindle-shaped and flat, SLC in 





Figure 4.8. Bone marrow-derived conditionally Ubr5mt cells adhere, proliferate 
and potentially senesce.  
Representative fields showing morphologies of bone marrow-derived conditionally 
Ubr5mt cells carrying tamoxifen-inducible p-CAG-Cre-ERT2 gene trap (x10). (A) 
Medium with non-adherent cells was discarded on the day 8 (no photos). First cells 
with enlarged and flattened morphology have been revealed after the first washing 













































Figure 4.9.A shows a comparison of cell morphology in three stages of MSCs cultures 
derived from mice with two different genotypes: (i) wild type C57BL/6; (ii) 
conditional Ubr5 mutant mice carrying TAM-inducible gene trap. The percentage of 
SLC rises with the increasing time in culture for both wild type and experimental cells 
(Figure 4.9.B). However, cells carrying TAM-inducible Cre gene trap exhibited 
increased % of SLC at earlier time points (e.g., a two-fold increase at day 18).  
  
When culture reached about 70% confluency (day 10) it was split 1:2 to avoid full 
confluency. (B) First passage, percentage of cells with flat, senescence-like 
morphology increased to 30% on day 16. Culture was split 1:1 after reaching 60% of 
confluency on day 16. The plate surface was dominated by large, flat cells. (C) Late 
stage, cells were split for the second time, the percentage of flat cells flat cells 
increased to 72%, no further proliferation was noticed. (D) The graph shows the 
changes in percentage of spindle-shaped and flat, senescence-like cells in the culture 




Figure 4.9. Comparison of bone marrow-derived adherent cells (BMACs) 
morphology in cultures derived from mice with different genotypes.  
(A) (i) Conditionally Ubr5 mutant mice carrying TAM-inducible p-CAG-Cre-ERT2 
gene trap on the left and (ii) wild type C57BL/6 mice on the right. (B) Comparison of 
the percentage of spindle-shaped and flat, senescence-like cells in the wild type (WT) 
and conditional Ubr5mt (EXP) culture over time. The percentage of senescence-like 
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4.1.2.2. Tamoxifen treatment of Ubr5mt BMACs to induce pCAGG-Cre-ERT2 
gene trap. 
Based upon in vivo observations in control and Ubr5mt articular cartilage, I 
hypothesised that UBR5 utilises Hedgehog signalling to influence the activity of an 
AC-resident stem population. I planned to address this hypothesis by investigating the 
chondrogenic potential of UBR5-deficient stem/progenitor cells in an in vitro model 
of chondrogenesis. As I managed to isolate conditional Ubr5mt primary MSCs 
carrying TAM-inducible pCAGG-Cre-ERT2 system, I attempted to optimise the 
concentration and the time of exposure to TAM required to induce Cre recombination 
in MSCs. Despite problems with isolation and a high percentage of SLC in conditional 
Ubr5mt primary MSCs, there was still a population of spindle-shape MSCs in the 
culture. I decided to use these cells to (1) optimise the concentration and the time of 
exposure to TAM required to induce Cre recombination in MSCs and (2) assess their 
chondrogenic potential. This decision was based on the limitations in availability of 
pCAGG-Cre carrying animals. 
Optimisation of tamoxifen-mediated recombination conditions  
Day 15 MSCs were harvested and seeded in 96-well plate. Once adhered they were 
treated with various concentrations of TAM (0.1µM-5µM) over different periods of 
time (24-96h). The viability of the cells and the efficiency of recombination was 
checked every 24h. Trypan Blue staining was used to determine cell viability by 
detecting the absence/presence of cell staining (132). Cell scoring for the range of 
TAM concentration and timing revealed no dramatic cell loss/death. Also, no change 
in cell morphology was observed (Figure 4.10). This suggested that even the highest 
TAM concentration did not have an obvious cytotoxic effect on MSCs.  
  
However, cells carrying TAM-inducible Cre gene trap seemed to change their 
morphology quicker than wild type cells (on day 18 almost 2x more SLC in EXP 
culture). Images taken at x10 magnification; scale bar: 50µm 
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Figure 4.10. Optimisation of Tamoxifen concentration and treatment period 
required to cause tamoxifen-mediated UBR5 expression loss. 
Representative fields showing cell morphologies for two highest tamoxifen 
concentrations used – 5µM and 1µM for 5 different periods of treatment – 0, 24, 48, 
72 and 96h. No dramatic cell death/loss or changes in morphology was observed. 
Images taken at x4 magnification; scale bar: 200µm 
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To determine the effectiveness of TAM-induced Cre-mediated recombination of the 
Ubr5mt gene trap I measured the expression of β-galactasidase (-Gal) activity.   -
Gal staining should only be detected in cells harbouring the gene trap in mutagenic 
orientation because only then cells produce a functional -Gal enzyme. Assessment of 
the effectiveness of Ubr5 mutation revealed no signs of β-gal activity even after 4 days 
of exposure to the highest concentration of TAM (data not shown). In conclusion, none 
of the applied doses induced Cre-mediated recombination of the Ubr5mt gene trap. 
Potential reasons included too low concentrations or dose duration. Alternatively, the 
SLC cells that were the predominant cell types in the culture may be refractory to 
TAM-mediated stimulation of Cre. A failure of the β-gal assay reagents remains a 
possibility, which could have been addressed with a suitable positive control (e.g. 
transfection of a LacZ expression plasmid into the MSCs. 
Chondrogenic potential of UBR5-deficient MSCs 
Due to limited availability of pCAGG-Cre carrying cells it was decided to conduct an 
experiment (in parallel to TAM optimisation) to check if UBR5-deficient MSCs 
maintained the ability to differentiate into chondrocytes. Cells were treated with TAM 
at a concentration of 1µM for 4 days - as recommended by Dr You-Ying Chau from 
School of Clinical Sciences (University of Edinburgh).  
Following the TAM-treatment, MSCs were then used for micromass-based 
chondrogenic differentiation assay. TAM-treated or vehicle-only control cells were 
plated as a 30µl micromass in a 24-well plate and were exposed to chondrogenic 
medium for 18 days. Over the time of chondrogenic stimulation, TAM-treated and 
control micromass cultures disintegrated (Figure 4.11). The failure of micromass 
formation/maintenance was therefore not a property associated with loss of Ubr5 
function, but from the presence of Cre-ERT2. The high % of SLC could also account 
for a lack of success in micromass culture, with SLC potentially losing MSC-
associated stem/progenitor properties and, in a consequence, an ability to differentiate 

















Expression of Ubr5 in BMACs carrying tamoxifen-inducible gene trap after 
tamoxifen treatment – RT-PCR 
Based on in vivo data, I knew that TAM-treatment could manifest an early OA-like 
and heterotopic ossification phenotype in conditional Ubr5mt mice carrying TAM-
inducible pCAGG-Cre-ERT2 system. These observations indirectly suggested that 
TAM-mediated Cre-ERT2 could promote recombination of the Ubr5mt gene trap and 
consequently a reduction in Ubr5 expression. Using RT-PCR on isolated RNA, I 
wished to determine if the same events could occur in TAM-treated pCAGG-Cre-
ERT2 carrying conditional Ubr5mt MSCs. RT-PCR analysis for Ubr5 expression was 
carried out on RNA extracted from TAM- and control-treated cells. According to PCR 
products on the agarose gel, both cell types expressed UBR5 at a similar level (Figure 
4.12). This indicated that TAM-induced loss of Ubr5 either did not occur or was not 
very efficient. Based on a detrimental effect of SLC in the culture, repeating the assay 
using Day 8 MSC populations could have increased the effectiveness of TAM-
mediated recombination. 
  
Figure 4.11. Micromass-based chondrogenic differentiation assay.  
Toluidine blue staining of micromass formed from TAM-treated (A) or ethanol-treated 
(vehicle) (B) conditional Ubr5mt BMACs after incubation in chondrogenic medium. 
After 18 days of chondrogenic stimulation, both micromass cultures disintegrated and 
cells died. Images taken at x10 magnification; scale bar: 100µm 
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In addition to PCR products in the predicted lanes (Figure 4.12, lanes 1, 4, 7, 10), I 
also detected PCR products in the ‘no RT-primer’ negative control lanes (Fig 4.12, 
lanes 2, 5, 8, 11). To investigate this unexpected PCR product, I first checked if 
expected length of PCR product for genomic DNA was the same for a reverse-
transcribed mRNA target. Comparison of genomic and mRNA-derived PCR products 
using gene specific primers are shown in Table 4.1.  
Figure 4.12. RT-PCR analysis of Ubr5 expression in BMACs carrying tamoxifen-
inducible gene trap after tamoxifen treatment (1µM).  
RT-PCR was performed to verify if TAM-mediated Ubr5 expression loss was 
successful. Three type of templates were used in PCR step – (i) generated with reverse 
transcriptase (RT) and 3’ primer (either Ubr5 or Actb) (ii) with RT but no primers 
(negative control), (iii) water (negative control). As a control I used BMACs treated 
with 100% ethanol (vehicle for tamoxifen). β-actin (Actb) was used as an external 
positive control to check if RT-PCR worked. According to PCR results, UBR5 was 
expressed both in TAM- and vehicle-treated cells. The unexpected product was 
detected in the negative controls with template generated without primers. PCR 
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Table 4.1. Product sizes for β-actin and Ubr5 primers used for RT-PCR 
optimisation. 
Type of a template 
for PCR 
Length of expected 
PCR product for 
Actb primers 
Length of expected 
PCR product for 
Ubr5 primers 
Genomic DNA 914nt 4456nt 
mRNA 460nt 84nt 
 
According to the results of the alignment, PCR product generated with genomic DNA 
template would be much longer than those of reverse-transcribed targets. This 
therefore excluded priming off genomic DNA as means to produce a PCR product. 
Other possibilities included (i) fragmented genomic DNA isolated in the RNA 
extraction process acted like random primers in the first step of RT-PCR and (ii) the 
RNA was somehow contaminated with oligo(dT) or random primers. To address these 
possibilities, I treated the isolated RNA with DNAse. Despite this extra step the PCR 
product pattern on the gel was the same as for non-DNAse-treated RNA (Figure 4.13).  
Therefore, elimination of DNA contamination did not solve the problem. No bands in 
the lanes with no-reverse transcriptase control (Figure 4.13, lane 2, 5) also confirmed 





























Another possible reason for the occurrence of the product was that reverse 
transcriptase was still active during the PCR step. Initial protocol did not include an 
inactivation of reverse transcriptase after the first RT-PCR step and 2 minutes of initial 
denaturation step in PCR reaction could have been too short to fully inactivate the 
enzyme (recommended 5 minutes of heat treatment according to the manufacturer’s 
instructions). To verify the hypothesis, I incubated the reaction mix for 5 minutes in 
Figure 4.13. RT-PCR analysis of Actb expression in wild type BMACs with and 
without DNAse treatment.  
RT-PCR was performed to investigate the source of undesired PCR product in one of 
the negative controls (cDNA template „generated” without primers in 1st step) in 
experiment presented on figure 4.12. The gel shows the comparison of PCR products 
obtained using DNAse treated (left) and non-treated (right) RNA. The aim of DNAse 
treatment was to eliminate genomic DNA contamination. Three conditions were used 
for analysis of beta-actin: (i) the experimental reaction conditions including reverse 
transcriptase (RT) and 3’ primer, (ii) without reverse transcription but with 3’ primer 
and (iii) with RT and no primers. Despite the DNAse treatment, product pattern on the 
gel was the same as for non-treated RNA. No bands in the lane where the template for 
PCR was „generated” without RT suggests that this unexpected product is RT 
dependent. PCR products were visualized in 3% agarose. 
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99°C after RT step and used it as a template in PCR with non-preheated template as a 
control. This time no PCR products were detected in the RT-inactivation step (Figure 
4.14). This result confirmed the hypothesis that the unexpected PCR product resulted 
from RT activity in PCR step, which validated the reliability of results presented in 
figure 4.12.  
  
Figure 4.14. RT-PCR analysis of Actb expression in wild type BMACs with and 
without heat inactivation of Reverse Transcriptase.  
RT-PCR was performed to verify if the reason for an unexpected PCR product in one 
of the negative controls is that reverse transcriptase is still active during the PCR step. 
The gel shows the comparison of PCR products generated in five different conditions: 
with template generated (i) with reverse transcriptase (RT) and oligo(dT) primers, (ii) 
without RT but with oligo(dT) primers, (iii) with RT but no primers and no heat 
inactivation, (iv) with RT but no primers – with heat inactivation and (v) with water.  
No bands in the lane where the PCR template was pre-heated in 99°C for 5 min 
confirmed the hypothesis that this unexpected product resulted from RT activity. PCR 
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Expression of Ubr5 in BMACs carrying tamoxifen-inducible gene trap after 
tamoxifen treatment – qRT-PCR 
RT-PCR is not a quantitative method, therefore by using it to verify the efficiency of 
TAM-induced Cre recombination I could only reliably check if Ubr5 was expressed 
or not. To examine if there was any change in the level of Ubr5 expression in TAM-
treated cells I decided to use qRT-PCR with GAPDH as a housekeeping gene (its 
transcription should not be affected by experimental factors).  
Data were analysed by relative quantification using StepOne Software (Version 2.3). 
Relative quantification relies on the comparison between expression of a target gene 
normalised to a housekeeping gene in experimental sample versus control samples. 
There was no significant difference in GAPDH expression between treatment groups, 
as it was expected. To determine the change in Ubr5 expression in TAM- and ethanol-
treated cells the cycle threshold values were measured and relative expression was 
calculated from 2^ -ΔΔCt values (131).   
Calculation of the relative fold change showed an 5% decrease in Ubr5 expression 
following TAM treatment comparing to the control (vehicle-treated) cell population, 
however, this must be taken with caution due to variation between three TAM-treated 
technical replicates (Figure 4.15.A). The problems with reproducibility could result 
from a pipetting error or the fact that StepOnePlus™ machine was not calibrated at 
that time. Moreover, during calibration of the instrument the contamination of 
fluorescent material was found, which could also affect the data I generated. 
Unfortunately, due to limited amount of RNA isolated from TAM/ethanol treated 





Figure 4.15. qRT-PCR analysis of Ubr5 expression in BMACs carrying TAM-
inducible gene trap after tamoxifen (TAM) treatment.  
qRT-PCR was performed to examine changes in the level of Ubr5 expression in TAM-
treated cells. (A) Amplification plot for Ubr5 expression in (A) TAM-treated and (B) 
EtOH-treated Ubr5mt BMACs. There was a problem with reproducibility between 
technical replicates for TAM-treated cells (A). It made the results of experiment 
difficult to interpret. (C) Expression fold change of Ubr5 relative to vehicle-treated 
Ubr5mt BMACs. There are signs of a decrease in Ubr5 expression in TAM-treated 
cells, but due to the problems with reproducibility between replicates this experiment 
should be repeated. TAM – tamoxifen, EtOH – ethanol (vehicle for tamoxifen) 
 


















B. Amplification plot for Ubr5 expression in EtOH-treated Ubr5mt BMACs     




To verify if any of the issues mentioned above was an actual reason for the lack of 
reproducibility between technical replicates I performed the experiment on RNA 
isolated from WT MSCs using Lightcycler ® 480 II Instrument (Qiagen) with β-actin 
as a gene of interest and GAPDH as a housekeeping gene; the conditions stayed the 
same. Results of the reaction confirmed the issue with the StepOnePlus™ machine, 
the fluorescent signal for all three technical replicates crossed the threshold at 
approximately the same point (data not shown), which is expected for properly carried 
out qRT-PCR. Based on the results above, the qRT-PCR should be performed on 
Lightcycler ® 480 II Instrument to avoid the lack of reproducibility in the future and 
to generate reliable data.  
To conclude, RT-PCR, qRT-PCR and β-GAL assays suggested that TAM-treatment 
of conditional Ubr5mt primary MSCs carrying TAM-inducible gene trap did not cause 
Ubr5mt recombinant nor a significant decrease in Ubr5 expression. 
Conclusions 
The WT bone marrow-derived adherent cells were successfully isolated and, according 
to ISCT criteria, characterised as MSCs. Unfortunately, problems with culturing and 
modifying of experimental Cre-ERT2-expressing MSCs made the proposed studies 
unfeasible within the time frame of the Master by Research studies. Therefore, I started 
working on the second aim of my project linked to the Ubr5mt heterotopic tendon-
ossification phenotype.   
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4.2. Histological analysis of tendons in murine hind limbs 
Skeletal development is carefully regulated to maintain a functioning skeleton, but in 
certain diseases heterotopic ossification (HO) can appear in soft tissue. The Ditzel lab 
identified a role of UBR5 protein in controlling heterotopic tendon ossification in the 
mouse limb. Using Cre system under the control of Prx1 promoter, combined with a 
Ubr5 mutant allele (Ubr5mt) UBR5 function was deleted in the developing murine 
embryonic limb bud. µ-CT analysis revealed HO in Ubr5mt adult animals and 
histological analysis showed the presence of chondrocytes within the tendon. Ubr5mt 
animals additionally treated with the Hh pathway antagonist cyclopamine showed an 
increased level of HO in comparison with those treated with an inactive cyclopamine 
analogue. Cyclopamine treatment in wild-type mice did not promote HO, suggesting 
that Ubr5mt background sensitises tendons to Hh pathway inhibition and ossification. 
Based on these findings in vitro I hypothesise that UBR5 regulates stem/progenitor 
behaviour to control tendon homeostasis through the activity of Hh signalling 
pathway. I aimed to address this hypothesis by characterisation of the existing 
histological material collected from Ubr5mt mice potentially affected by ossification. 
4.2.1. Histological staining 
The first part of the analysis of material collected from 6 months old Prx1-Cre 
homozygous Ubr5 mutant mice was based on histological staining. C57BL/6 WT mice 
tissue was used as a control. Dissected hind limbs were fixed, decalcified, divided into 
knee and foot part and sectioned separately. Every 10 section was stained with H&E 
and TB and scanned on slide scanner with 40x magnification. Selected section 


























H&E staining of the Ubr5mt Achilles tendon revealed cellular changes in both, 
midsubstance and enthesis. Normal tendon midsubstance should be built of 
extracellular matrix and elongated, fibroblast cells called tenocytes (Figure 4.16, left), 
however histological staining of Ubr5-defficient tissue showed the occurrence of 


























Figure 4.16. Histological sections of the Achilles tendon enthesis and 
midsubstance. Comparison of control and Ubr5mt animals  
H&E staining of the Achilles tendon revealed the occurrence of chondrocyte-like, 
round cells in the fibrous connective tissue zone of the enthesis and in the tendon 
midsubstance (black arrows) in Ubr5mt samples. Images taken at x10 magnification; 
scale bar: 50µm. AT – Achilles tendon, ET – insertion site (enthesis). 
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Figure 4.17. (A) Histological sections of the proximal patellar tendon (PT) enthesis 
and (B) patellar tendon midsubstance. Comparison of control and Ubr5mt 
animals  
(A) H&E staining of the PT isolated from mutant animals revealed increased number 
of chondrocyte-like, round cells in proximal tendon enthesis (black arrows), 
comparing to control tissue. Dark blue/violet staining of the enthesis observed on 
mutant knee section stained with toluidine blue (red arrow) showed higher 























































Beside the midbody, an increased number of chondrocyte-like cells has been revealed 
in Achilles tendon enthesis collected from mutant animal. A similar situation has been 
observed for the proximal patellar tendon enthesis (Figure 4.17), with addition of 
higher concentration of proteoglycans in extracellular matrix recorded on mutant 
sections stained with TB (red arrows, Figure 4.17). Interestingly, the patellar tendon 
midsubstance staining doesn’t display any cellular changes for either mutant or wild 
type samples.  
4.2.2. Optimisation of IHC staining 
Before I decided to analyse an experimental material using IHC staining, I decided to 
optimise the protocol to eliminate the risk of non-specific signal.  
4.2.2.1. Endogenous biotin activity detection 
Some tissues may contain endogenous biotin, therefore when using avidin-biotin-
based methods, the potential interference of internal biotin has to be ruled out, 
otherwise it may lead to occurrence of strong, unwanted, non-specific background 
staining.  
To check if the examined tissue contained endogenous biotin selected knee and feet 
sections were dewaxed, rehydrated and treated with hydrogen peroxide to rule out 
staining caused by endogenous peroxidase. In the next step tissue was exposed to ABC 
reagent (avidin-biotinylated enzyme complex) for 30 min, followed by colour 
development using DAB reagent. Sections were then dehydrated, mounted and 
scanned. Figure 4.18 presents no staining of the examined sections. This result 
confirmed that analysed tissue didn’t contain endogenous biotin, hence the extra 
blocking step was not necessary.  
 
 
(B) H&E staining of patellar tendon midsubstance showed no cellular changes in 
Ubr5mt samples. Images taken at x10 magnification; scale bar: 50µm. ET – insertion 














4.2.2.2.Optimisation of protein blocking reagent 
Before application of antibodies to detect proteins by IHC it is necessary to block all 
epitopes on the tissue sample to prevent the nonspecific binding of the antibodies. 
Otherwise, the antibodies may bind to any epitopes they have affinity for on the 
sample, independent of specificity. 
To reduce nonspecific reactions, the protein blocking reagent was applied on the 
sample prior to incubation with the primary antibody. In theory, any protein which 
does not have affinity for the target antigen could be used in a blocking step, however, 
there are certain ones which perform better than the others. As there is no protein 
blocking buffer which works well for every IHC, the optimisation step involving 
application of various blocking reagents is very important to obtain the best and the 
most specific results.  
Four different protein blocking buffers were empirically check to verify which one 
would be the most efficient for examined tissue: serum matching the species of the 
secondary antibody (10% in PBS-T), BSA (3% in PBS-T), non-fat dry milk (5% in 
PBS-T) and commercial blocking buffer (DAKO). The expression of two antigens was 
Figure 4.18. Endogenous biotin activity test.  
Endogenous biotin activity in analysed tissue was verified by incubation of sections 
directly with ABC complex and then DAB, without application of primary and 
secondary antibody. No endogenous biotin activity was detected (no brown staining 
after incubation with DAB). Images taken at x5 magnification; scale bar: 100µm. AC 
– articular cartilage, AT – Achilles tendon, ET – insertion site (enthesis), GP – growth 






























compared: UBR5, a protein ubiquitously expressed in mammalian tissues and V5, a 
synthetic, virus-derived Tag peptide, normally not expressed in mammalian cells, 
hence no signal was expected. 
Figure 4.19 shows the results of the optimisation of the blocking step. Non-fat dry milk 
turned out to be the very successful in blocking the background staining, but the overall 
cellular pattern in ET and AC area was similar for both UBR5 and V5. DAB staining 
for BSA-based blocking buffer was the same for both antibodies. The use of Dako 
Protein Block and Goat serum resulted in noticeable stronger signal for anti-UBR5 
antibody than for anti-V5, however Dako Protein Block was more efficient in blocking 
background staining.  
Among all four blocking reagents, non-fat dry milk and Dako Protein Block proved to 
be the most effective in blocking the background staining, however the latter was more 
efficient in blocking non-specific binding for anti-V5 antibody, therefore I decided to 


































































































4.2.2.3.Secondary antibody - non-specific binding test. 
Another cause of unwanted background immunostaining may be a nonspecific binding 
of secondary antibody to endogenous Fc receptors. In order to avoid it the IHC 
protocol includes the extra protein blocking step, but in some situations, it might not 
be sufficient. To confirm if any “sticky” site remained on the examined tissue after the 
blocking step, I carried out IHC staining according to standard protocol, skipping the 
primary antibody incubation step.  
Figure 4.20 shows no staining of examined sections after incubation with DAB 
reagent, which confirmed that no non-specific secondary antibody biding occurred and 
the protein blocking step was sufficient.  
The optimisation of the “non-specific staining” blocking step for IHC was carried out 
on sagital sections of murine knee joint using four common blocking agents: non-fat 
dry milk (5% in PBS-T), Dako serum-free Protein Block, Bovine Serum Albumin 
(BSA, 3% in PBS-T) and Goat Serum (10% in PBS-T). The expression of two antigens 
was compared – UBR5 (ubiquitously expressed protein) and V5 (synthetic, virus-
derived Tag peptide, normally not expressed in mammalian cells, no signal expected). 
To check UBR5 expression antibody raised against EDD, human homologue of UBR5, 
was used as these two proteins are highly conserved. Milk blocked most of the staining 
for both antigens, signal pattern for Dako Protein Block and BSA is the same for UBR5 
and V5. Goat serum blocked unspecific staining of the tissue, but overall cellular 
pattern in ET and AC area remained similar. Images taken at x5 magnification; scale 
bar: 100µm. AC – articular cartilage, AT – Achilles tendon, ET – insertion site 






Figure 4.20. Secondary antibody - non-specific binding test.  
Non-specific binding of secondary antibody was examined by omitting incubation 
with primary antibody, when following IHC protocol. There was no non-specific 
binding of secondary antibody observed (no brown staining after incubation with 
DAB). Images taken at x10 magnification; scale bar: 100µm. AC – articular cartilage, 
AT – Achilles tendon, ET – insertion site (enthesis), GP – growth plate, HB – heel bone 


























































4.2.3. IHC analysis of Hh signalling pathway markers on patellar tendon 
As mentioned earlier, H&E staining revealed some severe cellular changes in proximal 
patellar tendon enthesis after UBR5 loss. The last part of my research was to check if 
Hh signalling pathway was involved in reported cellular changes, to verify the 
hypothesis that UBR5 control tendon homeostasis through influencing activity of Hh 
family members. A batch of blank slides with Ubr5mt murine knee containing proper 
tendon section was chosen for immunohistochemistry staining using antibodies against 
three Hh signalling pathway molecules – IHH, GLI1 and PTCH1. 
IHC analysis of control and Ubr5mt knee sections displayed an increase in a signal for 
two out of three antibodies used to verify the Hh signalling pathway members 
expression in the patellar tendon enthesis (Figure 4.22, red dashed-line marked area, 
middle column). Relative to control, Ubr5mt tendon displayed increased staining for 
anti-IHH and anti-PTCH1 antibody, however intensity of GLI1 staining did not 
changed.   
These data suggest that UBR5 loss activates Hh signalling pathway in patellar tendon 
enthesis.  
Unfortunately, due to the limited time frame of my master studies I did not manage to 
analyse the cellular profile and Hedgehog signalling pathway markers in Achilles 



















































Figure 4.22. IHC analysis of Hedgehog signalling components in the proximal 
patellar tendon enthesis. Comparison of control and Ubr5mt animals. 
IHC analysis of control and Ubr5mt knee sections revealed an increased expression of 
two components of the Hh pathway in the proximal patellar tendon enthesis (red 
dashed-line marked area). Relative to control, Ubr5mt tendon displayed increased 
staining for IHH and PTCH1, however intensity of GLI1 staining did not changed.   




The overall aim of my research was to investigate the role of UBR5 protein in the 
skeletal tissue homeostasis. The project has been divided into two separate parts, the 
first one based on experiments in-vitro using primary cell line isolated from mice, and 
the second based on in vivo studies examining tissue isolated from mice with various 
genotype.  
5.1.  Chondrogenic potential of Ubr5-deficient mesenchymal 
stem/progenitor cells 
As already mentioned in chapter 2, Ditzel group identified a novel role for UBR5 
protein in maintaining AC homeostasis and in suppressing OA (data not published). 
Based upon these in vivo observations (and on earlier studies on Hyd in Drosophila), 
I hypothesised that UBR5 utilises Hh signalling pathway to influence the activity of 
an AC-resident mesenchymal stem/progenitor cell. The main aim for the first months 
of my research was to address this hypothesis by investigation of chondrogenic 
potential of UBR5-deficient stem/progenitor cells in an in vitro model of 
chondrogenesis.  
The first achieved objective in this part of the project was the establishment of an in 
vitro system to isolate and culture MSCs from bone marrow. I optimised an isolation 
and culture conditions using bone marrow collected from wild type C57BL/6 mice.   
The isolation process was based on minimal criteria proposed by ISCT (141), which 
is a standard, widely-used method for isolation of MSCs. The first criterion is their 
ability to adhere to plastic. The initial bone marrow incubation time used to allow cells 
to adhere to plastic surface varies from 3h (152) up to 3 days (142, 153) in published 
protocols. In my first experiment, I incubated bone marrow for 24h before medium 
change, according to the protocol provided by Dr Antonia Sophocleous; I managed to 
isolate adherent cells, however the yield was too low to use them in any of the planned 
experiments. One reason for that could have been a very small number of MSCs 
adhered in the initial step. I therefore decided to extend the initial incubation time to 
72h according to the protocol published by Meirelles et all (2003)(153), which resulted 
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in a higher number of adhered cells, and, consequently, increased the yield of MSCs 
obtained after 2 weeks of culturing.  
According to ISCT criteria for MSCs described by Dominici at all (2006)(141), beside 
the ability to adhere to plastic surface, they should express group of positive surface 
markers, however, as there is no universal marker characteristic only for MSCs, they 
also should lack expression of markers typical for hematopoietic stem cells (HSCs).  
To address if isolated adherent cells were MSCs I decided to analyse the expression of 
cell surface markers using RT-PCR. It confirmed that isolated cells express 
mesenchymal stem cells’ markers – CD29, CD73 and CD105, although the 
hematopoietic cell markers were also detected, which suggested that isolated MSCs 
were contaminated with HSCs. These results go along with previous findings, 
according to which adherence-based isolation of MSCs from some species (including 
mice) can be problematic due to the unwanted growth of non-mesenchymal cells even 
after several passages (146). To avoid that situation in the future, the purity of isolated 
cells can be increased through a positive or negative selection using flow cytometry 
(154), however, negative selection of MSCs is usually preferred due to the fact that 
isolated cells remain untouched by beads, antibodies and magnets.  
To further confirm the MSCs identity, I verified their ability to differentiate by 
chondrogenesis assays.  Two types of high density culture in three-dimensional 
environment have been used to enhance cell-cell interactions favourable for 
chondrogenesis, micromass and pellet. After 3 weeks in micromass or in pellet culture, 
cells stimulated with chondrogenic medium stained violet/blue, which indicated the 
presence of proteoglycans which are characteristic for extracellular matrix synthesised 
by chondrocytes. Culture in control medium did not show any blue staining with 
toluidine blue and micromass/pellet seemed to disperse, which confirms that they 
didn’t differentiate.  
In conclusion, the results of toluidine blue staining along with the ability to adhere to 
plastic and expression of MSCs positive marker confirm that isolated cells meet 
minimal criteria for MSCs proposed by International Society for Cellular Therapy. 
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Once I was confident about isolation technique and culture condition of wild type 
MSCs I decided to start working with conditionally Ubr5mt primary mesenchymal 
stem cells carrying tamoxifen-inducible p-CAG-Cre-ERT2 system. The protocol for 
the isolation was the same as for WT MSCs.  
The first studies were carried out without TAM treatment to prevent any potential 
complications related to Cre-mediated recombination. However, they happened to be 
much harder to culture than WT, which was confirmed by studies described by 
McHaffie et al (2016) (155). They showed that when cultured, bone marrow cells 
carrying the CreERT2 construct may present a reduced colony forming ability. The 
first noticeable difference between WT and experimental MSCs for us was that the 
time required for cells to adhere was 2 times longer for conditionally Ubr5mt cells and, 
consequently, for culture to become ready for experiments. At the same time the 
percentage of senescence-like cells (SLC) rose with the increasing time of culture and, 
more importantly, cells carrying TAM-inducible Cre gene trap exhibited increased % 
of SLC at earlier time points than WT cells. The limited life span of primary MSCs in 
cultures in vitro significantly hampers their use in the research. Therefore, to avoid the 
early senescence in the future, the immortalization of the cells could be a solution to a 
short life span problem. For instance, Liu et all (2013) (156) showed that the absence 
of p53 (a tumour suppressor which is believed to be a crucial inhibitor of unlimited 
cell proliferation) delayed the senescence by extended passage number. 
Despite the problems with isolation and a high percentage of SLC in conditional 
Ubr5mt primary MSCs, I decided to use these cells to optimise the concentration and 
the time of exposure to TAM required to induce Cre recombination in MSCs and to 
assess their chondrogenic potential. This decision was based on the limitations in 
availability of pCAGG-Cre carrying animals. 
TAM-induced Cre-mediated recombination was measured by the expression of β-Gal 
activity.  Assessment of the effectiveness of Ubr5 mutation revealed no signs of β-gal 
activity even after 4 days-long exposure to the highest concentration of TAM, which 
means that none of the applied doses induced Cre-mediated recombination of the 
Ubr5mt gene trap. The potential reasons included too low concentrations or too short 
exposure. Another possible problem was that SLCs, being the predominant cell types 
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in the culture, may be refractory to TAM-mediated stimulation of Cre. A failure of the 
β-gal assay reagents remains a possibility, which in the future could be addressed with 
addition of a suitable a positive control (e.g. transfection of a LacZ expression plasmid 
into the MSCs). In addition to β-gal staining, the effectiveness of mutation for the 
highest concentration of TAM has been verified by RT-PCR and qRT-PCR. Both 
experiments showed no decrease in Ubr5 expression, which confirmed that tamoxifen 
did no induce Cre-mediated recombination.  
Altogether, RT-PCR, qRT-PCR and β-GAL assays suggested that TAM-treatment of 
conditional Ubr5mt primary MSCs carrying TAM-inducible gene trap did not cause 
Ubr5mt recombinant nor a significant decrease in Ubr5 expression. Alternative 
methods to reduce Ubr5 expression in MSCs were considered (i.e. siRNA, shRNA, 
CRISP-Cas9), but deemed too risky based on the limited time available.  
In parallel, I assessed the chondrogenic potential of tamoxifen-treated conditional 
Ubr5mt cells using a micromass culture. Over the time of the experiment, both control 
and TAM-treated micromass dispersed, which suggests that the failure of high density 
culture maintenance was associated with presence of Cre-ERT2 system, not with loss 
of UBR5. Once again, the high % of SLCs could also be a reason for unsuccessful 
micromass culture, with SLCs potentially losing stem/progenitor properties and, 
consequently, an ability to differentiate into chondrocytes. 
In the future, if a similar experiment is going to be repeated, the use of earlier passages 
of Ubr5mt MSCs could eliminate the high concentration of SCLs, one of the potential 
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5.2. The role of UBR5 protein in tendons ossification process 
The problem with isolating and culturing conditional Ubr5 mutant MSCs made the 
first part of the project not feasible in the limited time frame of my master studies, 
therefore I moved to the second part of my research, which concerned addressing the 
role of UBR5 protein in tendons homeostasis. 
As already mentioned, another role of UBR5 identified by Ditzel team was controlling 
the heterotopic tendon ossification in the mouse limb. I hypothesised that UBR5 
regulates stem/progenitor behaviour to control tendon homeostasis through the activity 
of Hh signalling pathway, similarly to AC. The main two objectives to achieve were 
establishing cellular changes in tendons after UBR5 loss and determination if aberrant 
Hedgehog signalling induces heterotopic tendon ossification. 
The first part of the research based on histological staining of UBR-deficient tissue 
confirmed previous findings of Ditzel lab, as they revealed a population of round cells 
resembling chondrocytes in a tendon midsubstance. An increased number of 
chondrocyte-like cells has been also revealed in Achilles tendon and in proximal 
patellar enthesis collected from mutant animal. These data suggest that the process of 
heterotopic ossification of the tendons may be similar to endochondral ossification 
process. To further investigate this hypothesis, the steps of tendon ossification should 
be established by IHC staining of Ubr5mt limbs sections collected from mice at 
different age.  
Before starting the IHC analysis of mutant tissue, I eliminated the possible reasons of 
unspecific staining in IHC protocol (i.e. insufficient blocking step, unspecific binding 
of secondary antibody or endogenous biotin activity). Then, in the last part of my 
project I examined if Hh signalling pathway was involved in reported cellular changes 
in patellar tendon enthesis. IHC staining was performed on Ubr5mt murine knee 
sections using antibodies against three Hh signalling pathway markers. The 
experiment revealed that Ubr5mt patellar tendon insertion site displayed an increased 
staining for anti-IHH and anti-PTCH1 antibody, however intensity of GLI1 staining 
did not changed. These data might suggest that UBR5 loss activate Hh signalling 
pathway in tendons, where, according to Liu et all (2012)(120), it is normally active 
only at the beginning of postnatal development of the insertion sites, however, the lack 
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of GLI1 staining is confusing. To verify the correctness of the result, it would be 
recommended to repeat IHC staining with a positive and a negative control for every 
antibody.  
Unfortunately, due to the limited time frame of my studies and time-consuming 
generation of Ubr5mt mice material for IHC staining I did not manage to analyse 
cellular markers and Hh signalling pathway in Achilles tendon.  
To conclude, I confirmed that UBR5 loss induce cellular changes in both Achilles and 
patellar tendon, however a further investigation is needed to confirm and explain the 
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